drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Amiodarone	Acenocoumarol	0.361	-3.21	None	1347 (348/999)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#9CBFDB	149.308823187095	0
Omeprazole	Diazepam	0.301	1.694	Moderate	32681 (21387/11294)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F5B4B4	3622.54020087413	1
Haloperidol	Biperiden	0.491	-1.819	Moderate	486 (185/301)		#ABCBE2	53.8708894349875	0
Omeprazole	Alprazolam	0.276	2.066	Moderate	22792 (15905/6887)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F4B1B1	2526.3895308688	1
Digoxin	Furosemide	0.379	-1.737	Moderate	978 (383/595)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#ACCCE3	108.406851579049	0
Indomethacin	Methotrexate	0.305	1.518	Major	882 (555/327)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F7B7B7	97.7656882338662	0
Mesalazine	Azathioprine	0.388	-1.376	Moderate	377 (169/208)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B1CFE5	41.7887352201446	0
Digoxin	Spironolactone	0.393	-1.953	Minor	423 (154/269)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#A9C9E1	46.8876259897113	0
Omeprazole	Clonazepam	0.267	1.609	Moderate	6113 (3929/2184)		#F6B6B6	677.598245094812	1
Acetylsalicylic acid	Insulin aspart	0.311	-2.246	Moderate	2395 (796/1599)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#A6C7E0	265.474856372006	0
Pravastatin	Fenofibrate	0.814	-2.258	Major	1404 (465/939)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#A6C7E0	155.627013923297	0
Omeprazole	Methotrexate	0.311	1.628	Major	3430 (2214/1216)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F6B6B6	380.199898687257	1.24599844298863e-94
Trimethoprim	Leucovorin	0.508	-2.553	Major	509 (155/354)		#A3C5DF	56.4203348197708	0
Alendronic acid	Ibuprofen	0.163	19.07	Moderate	5625 (5373/252)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#B32020	623.5056647568	1
Digoxin	Amiodarone	0.335	-2.795	Major	273 (78/195)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#A0C3DD	30.2608082628633	1.15926374835892e-270
Methotrexate	Hydroxychloroquine	0.346	3.742	Minor	254 (205/49)		#EB9C9C	28.1547446841293	9.46898729175759e-197
Acetylsalicylic acid	Gliclazide	0.359	-3.254	None	3813 (975/2838)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#9CBFDB	422.653706616476	0
Warfarin	Amiodarone	0.325	-2.647	Major	165 (49/116)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#A2C4DE	18.2894994995328	1.78859965253353e-171
Carbamazepine	Levetiracetam	0.527	-1.237	Moderate	238 (113/125)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B2D0E5	26.3812174599321	1.61401608988495e-197
Acetylsalicylic acid	Ibuprofen	0.147	-1.681	Major	12001 (4793/7208)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#ACCCE3	1330.25626359935	1
Acetylsalicylic acid	Glyburide	0.348	-2.773	Moderate	2095 (602/1493)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#A0C3DD	232.22122091831	3.5086211446805e-287
Trimipramine	Moclobemide	0.167	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Trimipramine.	#B32020	0.11084545151232	1
Digoxin	Carvedilol	0.359	-4.3	Moderate	441 (91/350)	Digoxin may increase the bradycardic activities of Carvedilol.	#90B6D6	48.8828441169331	0
Digoxin	Verapamil	0.425	-1.061	Moderate	115 (59/56)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B4D1E6	12.7472269239168	3.18085927603303e-88
Acetylsalicylic acid	Insulin detemir	0.314	-1.931	Moderate	900 (330/570)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#ABCBE2	99.7609063610879	2.88049656028863e-198
Atenolol	Ibuprofen	0.157	1.217	Moderate	4859 (2801/2058)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F8BABA	538.598048898362	1
Acetaminophen	Acenocoumarol	0.216	-1.638	None	3767 (1528/2239)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	417.554815846909	1
Amitriptyline	Duloxetine	0.344	6.789	Major	859 (759/100)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#DB7A7A	95.2162428490828	8.60424979742047e-81
Bisoprolol	Ibuprofen	0.133	-1.185	Moderate	5501 (2670/2831)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B2D0E5	609.760828769272	1
Tramadol	Fluoxetine	0.216	6.41	Major	1862 (1634/228)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#DD7E7E	206.39423071594	1
Propafenone	Acenocoumarol	0.355	-1.199	None	114 (55/59)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#B2D0E5	12.6363814724045	4.94058328099491e-79
Entacapone	Apomorphine	0.27	-2.236	Moderate	3 (1/2)		#A6C7E0	0.33253635453696	1.01483170110318e-05
Tramadol	Citalopram	0.217	3.459	Major	2302 (1829/473)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#EC9F9F	255.16622938136	1
Fenofibrate	Atorvastatin	0.45	-3.494	Major	2075 (503/1572)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#99BDDA	230.004311888064	1.35135176945538e-152
Warfarin	Propafenone	0.264	-1.23	Moderate	42 (20/22)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#B2D0E5	4.65550896351744	2.94464375180333e-45
Omeprazole	Ketazolam	0.272	2.372	None	1439 (1045/394)		#F2ACAC	159.506604726228	1
Propranolol	Rizatriptan	0.306	4.159	Moderate	226 (186/40)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#E89898	25.0510720417843	1.19390235641473e-77
Diclofenac	Alendronic acid	0.141	14.59	Moderate	1887 (1778/109)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#B32020	209.165367003748	1
Tramadol	Paroxetine	0.197	4.318	Major	1923 (1593/330)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#E89696	213.155803258191	1
Amitriptyline	Fluoxetine	0.293	6.649	Major	835 (736/99)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#DC7B7B	92.5559520127871	0.84077543187739
Simvastatin	Clarithromycin	0.089	1.546	Major	2527 (1601/926)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F6B6B6	280.106455971632	1
Trihexyphenidyl	Haloperidol	0.56	-1.204	Moderate	27 (13/14)		#B2D0E5	2.99282719083264	2.30521114517525e-30
Lamotrigine	Carbamazepine	0.521	1.046	Moderate	128 (69/59)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#F9BCBC	14.1882177935769	9.76750436723308e-80
Alendronic acid	Naproxen	0.156	16.536	Moderate	1637 (1553/84)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#B32020	181.454004125668	1
Digoxin	Propafenone	0.327	1.083	Moderate	42 (23/19)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F9BCBC	4.65550896351744	4.50217517727239e-34
Valproic acid	Carbamazepine	0.535	-1.605	Moderate	190 (78/112)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#AECDE3	21.0606357873408	2.47958321006006e-111
Simvastatin	Fenofibrate	0.394	-2.581	Major	2339 (707/1632)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#A3C5DF	259.267511087316	1
Methotrexate	Naproxen	0.232	2.026	Major	875 (607/268)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F4B1B1	96.9897700732799	1
Torasemide	Ibuprofen	0.175	1.98	Moderate	1787 (1231/556)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F4B1B1	198.080821852516	1
Donepezil	Quetiapine	0.349	1.406	Moderate	54 (33/21)		#F7B9B9	5.98565438166528	6.03383936034614e-45
Tacrolimus	Atorvastatin	0.41	-1.7	Moderate	746 (296/450)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#ACCCE3	82.6907068281907	2.2512613692824e-42
Diltiazem	Atorvastatin	0.481	-3.227	Moderate	921 (237/684)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#9CBFDB	102.088660842847	8.28569778562071e-137
Repaglinide	Gliclazide	0.224	-1.828	None	332 (126/206)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#ABCBE2	36.8006899020902	4.72553440673725e-47
Propranolol	Ibuprofen	0.185	2.252	Moderate	1509 (1080/429)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F2AEAE	167.265786332091	1
Prednisone	Acetylsalicylic acid	0.191	-1.927	Moderate	2688 (987/1701)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#ABCBE2	297.952573665116	1
Mesalazine	Mercaptopurine	0.281	-1.584	Moderate	29 (12/17)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#AECDE3	3.21451809385728	1.58655619290953e-35
Tramadol	Escitalopram	0.213	2.953	Major	1170 (898/272)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#EFA6A6	129.689178269414	1
Furosemide	Ibuprofen	0.224	1.249	Moderate	2260 (1317/943)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F8BABA	250.510720417843	1
Diltiazem	Amiodarone	0.376	-2.795	Major	140 (40/100)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#A0C3DD	15.5183632117248	1.23769701742932e-65
Atenolol	Gliclazide	0.332	-1.771	None	739 (286/453)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	81.9147886676044	0.651701826803211
Acetylsalicylic acid	Insulin glulisine	0.286	-2.648	Moderate	384 (114/270)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#A2C4DE	42.5646533807308	1.17543541266944e-82
Cyclosporine	Allopurinol	0.365	-3.415	Moderate	150 (37/113)		#9ABEDB	16.626817726848	2.2570048454109e-49
Omeprazole	Itraconazole	0.169	1.654	Moderate	1450 (941/509)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F6B6B6	160.725904692864	1
Haloperidol	Lithium cation	0.366	-1.374	Major	78 (35/43)	Lithium may increase the neurotoxic activities of Haloperidol.	#B1CFE5	8.64594521796095	2.36230431975731e-50
Fluvoxamine	Clomipramine	0.431	1.201	Major	82 (47/35)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F8BABA	9.08932702401023	7.71761554527394e-50
Tacrolimus	Nifedipine	0.398	-2.178	Moderate	171 (58/113)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#A8C8E1	18.9545722086067	5.11585919570385e-86
Carbamazepine	Simvastatin	0.363	1.07	Moderate	650 (354/296)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	72.049543483008	1
Levothyroxine	Iron	0.157	9.518	Moderate	454 (415/39)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#CD5A5A	50.3238349865932	1
Propranolol	Paroxetine	0.311	2.882	Moderate	456 (348/108)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F0A7A7	50.5455258896179	1
Sucralfate	Lansoprazole	0.352	1.772	Moderate	155 (103/52)		#F5B4B4	17.1810449844096	8.51760144101925e-37
Alprazolam	Clarithromycin	0.134	2.956	Moderate	1145 (879/266)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#EFA6A6	126.918041981606	1
Levothyroxine	Acenocoumarol	0.284	1.941	None	539 (369/170)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F5B2B2	59.7456983651404	1
Levothyroxine	Raloxifene	0.318	60.31	Moderate	479 (472/7)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	53.0949712744012	1
Propranolol	Primidone	0.26	1.17	Moderate	30 (17/13)	The metabolism of Propranolol can be increased when combined with Primidone.	#F8BABA	3.3253635453696	4.28805259159643e-23
Bisoprolol	Gliclazide	0.322	-3.601	None	1127 (267/860)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#97BCD9	124.922823854385	3.05236529566732e-08
Omeprazole	Flurazepam	0.269	2.205	Moderate	499 (355/144)		#F3AFAF	55.3118803046476	1
Omeprazole	Midazolam	0.255	1.533	Moderate	532 (336/196)		#F7B7B7	58.9697802045542	1
Phenytoin	Lamotrigine	0.526	-2.064	Moderate	74 (26/48)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#A9C9E1	8.20256341191167	6.55787560160394e-56
Fluoxetine	Clomipramine	0.369	2.052	Major	313 (218/95)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F4B1B1	34.6946263233561	6.04983904890813e-20
Cholestyramine	Ursodeoxycholic acid	0.349	1.61	None	56 (36/20)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F6B6B6	6.20734528468992	5.54066079280992e-32
Acetylsalicylic acid	Acenocoumarol	0.307	-3.799	None	1139 (259/880)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#96BBD9	126.252969272532	1
Diltiazem	Simvastatin	0.421	-2.005	Major	894 (320/574)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#A9C9E1	99.095833652014	1
Spironolactone	Enalapril	0.396	-3.191	Major	1160 (301/859)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#9CBFDB	128.580723754291	1
Fluconazole	Simvastatin	0.105	1.222	Major	1008 (582/426)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F8BABA	111.732215124418	1
Topiramate	Carbamazepine	0.495	-1.002	Moderate	146 (77/69)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	16.1834359207987	1.26876333129236e-52
Allopurinol	Acenocoumarol	0.333	-7.706	None	734 (93/641)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#699AC6	81.3605614100428	3.00785706607375e-69
Amitriptyline	Salbutamol	0.18	4.205	Moderate	764 (630/134)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#E89898	84.6859249554124	1
Simvastatin	Gemfibrozil	0.248	-2.949	Major	1775 (488/1287)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#9FC1DD	196.750676434368	1
Citalopram	Propranolol	0.312	2.24	Moderate	417 (298/119)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F2AEAE	46.2225532806374	1
Rivastigmine	Quetiapine	0.316	-1.447	Moderate	39 (17/22)		#AFCEE4	4.32297260898048	8.90462308876416e-32
Cyclosporine	Sulfamethoxazole	0.295	-2.05	Major	68 (24/44)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#A9C9E1	7.53749070283775	4.47886274473294e-43
Bisoprolol	Insulin aspart	0.291	-2.692	Moderate	535 (157/378)		#A2C4DE	59.3023165590912	2.21986608453236e-14
Raloxifene	Estriol	0.267	47.404	None	108 (106/2)		#B32020	11.9713087633306	1.40349161409206e-29
Bisoprolol	Salbutamol	0.15	-1.456	Moderate	1271 (552/719)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#AFCEE4	140.884568872159	1
Venlafaxine	Metoclopramide	0.123	4.506	Moderate	477 (398/79)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#E79494	52.8732803713766	1
Fluoxetine	Propranolol	0.319	2.806	Moderate	331 (251/80)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F0A7A7	36.6898444505779	1
Carbamazepine	Risperidone	0.425	-1.665	Moderate	117 (47/70)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#AECDE3	12.9689178269414	2.19766343615092e-46
Fenofibrate	Rosuvastatin	0.466	-4.343	Major	464 (95/369)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#90B6D6	51.4322895017164	2.89180957576717e-86
Amiodarone	Flecainide	0.19	-2.431	Major	73 (23/50)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#A5C6DF	8.09171796039935	3.47339818774705e-29
Propranolol	Escitalopram	0.297	1.712	None	306 (201/105)		#F5B4B4	33.9187081627699	0.441780229375235
Carvedilol	Insulin aspart	0.31	-3.714	Moderate	255 (59/196)		#96BBD9	28.2655901356416	2.38328108000626e-61
Cyclosporine	Atorvastatin	0.448	-1.693	Major	176 (70/106)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	19.5087994661683	2.45946187814299e-20
Phenytoin	Omeprazole	0.353	-1.527	Moderate	537 (227/310)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#AFCEE4	59.5240074621158	1
Risperidone	Donepezil	0.174	-1.118	Moderate	28 (14/14)		#B4D1E6	3.10367264234496	8.71531720134789e-21
Disopyramide	Sotalol	0.294	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Sotalol.	#B32020	0.11084545151232	1
Methotrexate	Ibuprofen	0.175	2.217	Major	800 (570/230)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F3AFAF	88.6763612098559	1
Omeprazole	Halazepam	0.257	2.421	Moderate	341 (249/92)		#F2ACAC	37.7982989657011	1
Ranolazine	Diltiazem	0.298	-2.744	Major	38 (11/27)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#A2C4DE	4.21212715746816	6.15971364496045e-25
Atenolol	Glyburide	0.343	-1.81	Moderate	364 (139/225)	Atenolol may increase the hypoglycemic activities of Glyburide.	#ACCCE3	40.3477443504844	1
Methotrexate	Amoxicillin	0.12	1.729	Major	792 (522/270)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F5B4B4	87.7895975977574	1
Acetaminophen	Warfarin	0.232	-1.669	Minor	541 (217/324)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#AECDE3	59.9673892681651	1
Atenolol	Salbutamol	0.145	1.1	Moderate	834 (460/374)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#F9BCBC	92.4451065612748	1
Fluconazole	Alprazolam	0.165	2.546	Major	477 (353/124)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F1ABAB	52.8732803713766	1
Ibuprofen	Carvedilol	0.114	-1.76	Moderate	1143 (444/699)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#ACCCE3	126.696351078582	1
Trimethoprim	Rifampicin	0.585	-1.556	Moderate	55 (23/32)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#AECDE3	6.0964998331776	7.21598978002814e-25
Topiramate	Lithium cation	0.367	1.858	Moderate	80 (54/26)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#F5B2B2	8.86763612098559	8.87978802291956e-20
Bisoprolol	Formoterol	0.201	-1.627	Moderate	761 (310/451)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#AECDE3	84.3533886008755	1
Propranolol	Sertraline	0.339	1.643	Moderate	278 (180/98)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F6B6B6	30.8150355204249	1
Citalopram	Acenocoumarol	0.349	-1.022	None	377 (197/180)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#B4D1E6	41.7887352201446	1
Carbamazepine	Atorvastatin	0.376	-1.337	Moderate	292 (133/159)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B1CFE5	32.3668718415974	1
Repaglinide	Glyburide	0.201	-1.785	None	135 (52/83)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#ACCCE3	14.9641359541632	6.12089760243016e-12
Citalopram	Clarithromycin	0.124	3.1	Major	585 (454/131)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#EEA4A4	64.8445891347071	1
Paroxetine	Risperidone	0.362	1.045	Moderate	271 (146/125)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F9BCBC	30.0391173598387	0.263436653870044
Simvastatin	Itraconazole	0.113	1.146	Major	682 (383/299)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F8BABA	75.5965979314022	1
Cyclosporine	Omeprazole	0.398	-1.947	Moderate	466 (170/296)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#ABCBE2	51.6539804047411	1
Valproic acid	Acetylsalicylic acid	0.358	-2.544	Moderate	488 (149/339)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#A3C5DF	54.0925803380121	1
Pyridostigmine	Prednisone	0.367	-1.206	Moderate	106 (51/55)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#B2D0E5	11.7496178603059	1.74046574802606e-29
Atorvastatin	Gemfibrozil	0.292	-4.045	Major	956 (207/749)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#93B8D7	105.968251645778	1
Haloperidol	Carbamazepine	0.398	-1.744	Moderate	64 (25/39)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#ACCCE3	7.09410889678847	1.28875845662582e-28
Dextromethorphan	Paroxetine	0.137	4.42	Major	410 (341/69)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#E79494	45.4466351200512	1
Prednisone	Acenocoumarol	0.206	-1.57	None	488 (203/285)		#AECDE3	54.0925803380121	1
Fluvoxamine	Olanzapine	0.497	-1.806	Moderate	68 (26/42)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#ACCCE3	7.53749070283775	1.83000699199873e-32
Ibuprofen	Acenocoumarol	0.133	-1.483	None	1105 (475/630)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	122.484223921114	1
Fluoxetine	Dextromethorphan	0.141	4.954	Major	340 (288/52)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#E48E8E	37.6874535141888	1
Bisoprolol	Repaglinide	0.32	-3.388	Moderate	395 (98/297)		#9ABEDB	43.7839533473664	2.20369548416414e-07
Sulfasalazine	Azathioprine	0.538	1.193	Moderate	21 (12/9)		#F8BABA	2.32775448175872	1.95423180202887e-11
Atorvastatin	Clarithromycin	0.105	-1.181	Major	804 (391/413)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B2D0E5	89.1197430159052	1
Sumatriptan	Ergotamine	0.227	4.344	Major	41 (34/7)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#E89696	4.54466351200512	9.47769291083538e-13
Ramipril	Spironolactone	0.393	-3.543	Major	271 (65/206)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#99BDDA	30.0391173598387	6.90387180500495e-18
Cyclosporine	Carvedilol	0.528	-2.039	Moderate	48 (17/31)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#A9C9E1	5.32058167259136	2.21229544740519e-15
Methotrexate	Acetylsalicylic acid	0.259	-1.502	Major	396 (169/227)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#AFCEE4	43.8947987988787	1
Folic acid	Phenytoin	0.363	-1.223	Moderate	67 (32/35)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#B2D0E5	7.42664525132543	3.11870362006866e-12
Metformin	Glucosamine	0.178	1.183	None	518 (295/223)		#F8BABA	57.4179438833817	1
Fluoxetine	Clarithromycin	0.127	5.748	Moderate	401 (347/54)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#E08585	44.4490260564403	1
Diazepam	Clarithromycin	0.254	2.814	Moderate	850 (645/205)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F0A7A7	94.2186337854719	1
Methimazole	Acenocoumarol	0.292	1.118	None	72 (40/32)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F9BCBC	7.98087250888703	1.47986645612833e-09
Acetylsalicylic acid	Glipizide	0.366	-2.578	Moderate	119 (36/83)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#A3C5DF	13.1906087299661	7.98345861593578e-18
Disopyramide	Bisoprolol	0.377	2.087	Major	10 (7/3)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#F3AFAF	1.1084545151232	0.000120974230263685
Paroxetine	Acenocoumarol	0.256	1.309	None	271 (161/110)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	30.0391173598387	1
Ibuprofen	Lithium cation	0.13	1.287	Moderate	461 (272/189)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F7B9B9	51.0997531471795	1
Sertraline	Clarithromycin	0.133	3.668	Moderate	352 (283/69)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#EB9E9E	39.0175989323366	1
Digoxin	Levothyroxine	0.314	2.034	Moderate	167 (116/51)		#F4B1B1	18.5111904025574	1
Amitriptyline	Carbamazepine	0.413	1.631	Moderate	144 (93/51)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F6B6B6	15.9617450177741	0.00630050495003267
Spironolactone	Losartan	0.363	-2.18	Major	292 (99/193)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#A8C8E1	32.3668718415974	1
Fluoxetine	Risperidone	0.369	1.06	Moderate	201 (109/92)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F9BCBC	22.2799357539763	0.489152202891089
Indomethacin	Alendronic acid	0.228	6.655	Moderate	211 (186/25)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#DC7B7B	23.3883902690995	1
Enalapril	Tizanidine	0.125	1.102	Major	395 (218/177)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#F9BCBC	43.7839533473664	1
Glimepiride	Repaglinide	0.265	-2.012	None	84 (30/54)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#A9C9E1	9.31101792703487	1.32450112362606e-09
Salbutamol	Clomipramine	0.153	2.668	Moderate	235 (176/59)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F0A9A9	26.0486811053952	1
Methadone	Cimetidine	0.087	Inf	Moderate	1 (1/0)	The metabolism of Methadone can be decreased when combined with Cimetidine.	#B32020	0.11084545151232	1
Bisoprolol	Glyburide	0.284	-3.242	Moderate	429 (110/319)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#9CBFDB	47.5526986987852	1
Ezetimibe	Cholestyramine	0.248	-1.304	Moderate	65 (30/35)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	7.20495434830079	2.11876937941511e-12
Fluvoxamine	Mirtazapine	0.366	1.141	Major	66 (37/29)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#F8BABA	7.31579979981311	7.04515109949369e-13
Zolmitriptan	Fluoxetine	0.223	8.114	Major	141 (127/14)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#D46A6A	15.6292086632371	1
Citalopram	Rizatriptan	0.252	9.77	Major	155 (142/13)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#CB5757	17.1810449844096	1
Cyclosporine	Ursodeoxycholic acid	0.479	-3.833	Minor	62 (14/48)		#96BBD9	6.87241799376384	8.19837320061984e-50
Rifampicin	Leflunomide	0.144	1.278	Major	17 (10/7)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#F7B9B9	1.88437267570944	4.37069403578847e-08
Paroxetine	Rizatriptan	0.257	6.907	Major	157 (139/18)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#DA7878	17.4027358874342	1
Fluoxetine	Oxycodone	0.257	3.383	Moderate	110 (87/23)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#EDA1A1	12.1929996663552	1
Methotrexate	Diclofenac	0.192	1.514	Major	412 (259/153)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F7B7B7	45.6683260230758	1
Fluoxetine	Acenocoumarol	0.303	1.02	None	244 (130/114)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F9BCBC	27.0462901690061	1
Almotriptan	Escitalopram	0.234	6.857	Major	78 (69/9)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#DA7878	8.64594521796095	0.0847260097776771
Zolmitriptan	Paroxetine	0.243	5.009	Major	165 (140/25)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#E48E8E	18.2894994995328	1
Spironolactone	Cholestyramine	0.268	-1.677	Moderate	55 (22/33)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#ACCCE3	6.0964998331776	3.8748286783366e-15
Hydrocortisone	Acetylsalicylic acid	0.177	-1.588	Moderate	426 (176/250)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#AECDE3	47.2201623442483	1
Cyclosporine	Nifedipine	0.502	-2.846	Moderate	39 (11/28)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#A0C3DD	4.32297260898048	6.26820046258242e-22
Erythromycin	Simvastatin	0.092	1.364	Major	399 (241/158)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F7B9B9	44.2273351534156	1
Zolmitriptan	Ergotamine	0.252	3.578	Major	45 (36/9)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#EB9E9E	4.9880453180544	1.12551520773364e-09
Trazodone	Donepezil	0.357	1.382	Moderate	28 (17/11)		#F7B9B9	3.10367264234496	1.74071304023623e-11
Fluoxetine	Rizatriptan	0.224	9.432	Major	127 (116/11)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#CD5A5A	14.0773723420646	1
Folic acid	Phenobarbital	0.271	-1.379	Moderate	67 (30/37)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#B1CFE5	7.42664525132543	4.00561026000366e-12
Acetylsalicylic acid	Methylprednisolone	0.203	-1.626	Moderate	400 (163/237)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#AECDE3	44.338180604928	1
Gliclazide	Carvedilol	0.343	-4.315	None	277 (57/220)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#90B6D6	30.7041900689126	2.10832134183548e-08
Glimepiride	Gemfibrozil	0.264	-3.899	Moderate	184 (41/143)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#94B9D8	20.3955630782669	1.20746993482365e-07
Fluoxetine	Lithium cation	0.39	1.416	Major	124 (76/48)	Lithium may increase the serotonergic activities of Fluoxetine.	#F7B7B7	13.7448359875277	0.0586706782235234
Ergotamine	Rizatriptan	0.326	3.801	Major	42 (34/8)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#EB9C9C	4.65550896351744	6.63010563938537e-09
Fluconazole	Fentanyl	0.359	-1.348	Major	161 (73/88)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B1CFE5	17.8461176934835	4.65120681956409e-05
Tramadol	Carbamazepine	0.305	1.385	Moderate	237 (144/93)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F7B9B9	26.2703720084198	1
Paroxetine	Carvedilol	0.324	-1.199	Moderate	230 (111/119)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#B2D0E5	25.4944538478336	1
Ranitidine	Acenocoumarol	0.308	-1.825	None	258 (98/160)		#ABCBE2	28.5981264901785	1
Bisoprolol	Salmeterol	0.258	-2.215	Moderate	477 (160/317)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#A8C8E1	52.8732803713766	1
Alprazolam	Itraconazole	0.151	2.205	Major	298 (212/86)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F3AFAF	33.0319445506713	1
Duloxetine	Ciprofloxacin	0.108	2.322	Major	338 (244/94)		#F2AEAE	37.4657626111641	1
Rizatriptan	Escitalopram	0.232	4.84	Major	109 (92/17)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#E59090	12.0821542148429	1
Sumatriptan	Paroxetine	0.229	6.58	Major	117 (103/14)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#DC7B7B	12.9689178269414	1
Alprazolam	Carbamazepine	0.274	1.358	Moderate	209 (126/83)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F7B9B9	23.1666993660749	1
Propranolol	Ergotamine	0.335	2.624	Moderate	59 (44/15)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F1ABAB	6.53988163922688	0.000215901579536916
Sertraline	Carvedilol	0.323	-1.571	Moderate	190 (79/111)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#AECDE3	21.0606357873408	1
Galantamine	Risperidone	0.34	-3.131	Moderate	19 (5/14)		#9DC0DC	2.10606357873408	1.72244588327592e-18
Verapamil	Atorvastatin	0.402	-2.137	Moderate	198 (68/130)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A8C8E1	21.9473993994393	1
Phenytoin	Furosemide	0.342	-1.193	Minor	62 (30/32)	Phenytoin may decrease the diuretic activities of Furosemide.	#B2D0E5	6.87241799376384	0.0299536520785465
Carbamazepine	Aripiprazole	0.338	1.988	Moderate	29 (20/9)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#F4B1B1	3.21451809385728	0.00011596157364147
Galantamine	Quetiapine	0.344	-1.597	Moderate	17 (7/10)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#AECDE3	1.88437267570944	1.02248301096949e-11
Simvastatin	Colchicine	0.182	-6.75	Major	746 (106/640)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#74A1CA	82.6907068281907	1
Fluoxetine	Carvedilol	0.305	1.066	Moderate	171 (93/78)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F9BCBC	18.9545722086067	1
Citalopram	Zolmitriptan	0.197	4.861	Major	148 (125/23)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#E59090	16.4051268238233	1
Repaglinide	Carvedilol	0.347	-4.174	Moderate	142 (30/112)		#91B7D7	15.7400541147494	2.56503856635034e-19
Atenolol	Insulin detemir	0.276	-1.304	Moderate	117 (54/63)		#B1CFE5	12.9689178269414	1
Donepezil	Sertraline	0.453	2.087	Minor	30 (21/9)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F3AFAF	3.3253635453696	2.99991212861118e-06
Simvastatin	Amiodarone	0.294	-3.805	Major	480 (109/371)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#96BBD9	53.2058167259136	1
Fluoxetine	Carbamazepine	0.305	1.835	Moderate	119 (80/39)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F5B2B2	13.1906087299661	1
Phenytoin	Dexamethasone	0.366	-1.942	Moderate	52 (19/33)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#ABCBE2	5.76396347864064	4.92745606851889e-12
Erythromycin	Alprazolam	0.109	2.806	Moderate	211 (160/51)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F0A7A7	23.3883902690995	1
Fluconazole	Atorvastatin	0.116	-1.307	Major	347 (160/187)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B1CFE5	38.463371674775	1
Fluconazole	Diazepam	0.244	2.359	Moderate	371 (269/102)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F2ACAC	41.1236625110707	1
Levofloxacin	Acenocoumarol	0.13	-1.822	None	263 (100/163)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	29.1523537477401	1
Clozapine	Haloperidol	0.294	-1.491	Major	7 (3/4)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#AFCEE4	0.775918160586239	3.19300479783702e-05
Ranolazine	Sotalol	0.662	-1.118	Major	4 (2/2)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.44338180604928	0.213396314667089
Citalopram	Oxycodone	0.289	2.183	Moderate	117 (83/34)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F3AFAF	12.9689178269414	1
Trospium	Tolterodine	0.453	7.155	Moderate	9 (8/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#D97575	0.997609063610879	0.00181157468953261
Clozapine	Flunitrazepam	0.104	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#B32020	0.22169090302464	1
Oxycodone	Sertraline	0.275	2.555	Moderate	81 (60/21)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F1ABAB	8.97848157249791	1
Pravastatin	Gemfibrozil	0.316	-2.394	Major	223 (71/152)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#A5C6DF	24.7185356872473	1
Propranolol	Salbutamol	0.176	1.276	Major	313 (184/129)		#F7B9B9	34.6946263233561	1
Digoxin	Alprazolam	0.264	1.066	Moderate	160 (87/73)		#F9BCBC	17.7352722419712	1
Duloxetine	Nortriptyline	0.377	4.472	Major	30 (25/5)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#E79494	3.3253635453696	3.78742139289299e-05
Clozapine	Triazolam	0.543	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine.	#B32020	0.11084545151232	1
Carbamazepine	Sertraline	0.38	1.908	Moderate	94 (64/30)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F5B2B2	10.4194724421581	1
Fenofibrate	Fluvastatin	0.413	-2.53	Major	124 (38/86)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#A3C5DF	13.7448359875277	9.33108330869972e-05
Azathioprine	Acenocoumarol	0.409	1.315	None	42 (25/17)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#F7B9B9	4.65550896351744	1
Atenolol	Repaglinide	0.312	-2.081	Moderate	186 (65/121)		#A9C9E1	20.6172539812915	1
Omeprazole	Cilostazol	0.272	-6.225	Major	578 (88/490)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#7AA6CD	64.0686709741209	1
Spironolactone	Tolevamer	0.31	-4.472	Moderate	45 (9/36)		#8EB5D5	4.9880453180544	1.77463071579398e-22
Acetylsalicylic acid	Ginkgo biloba	0.283	-1.105	Moderate	169 (85/84)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#B4D1E6	18.7328813055821	1
Clozapine	Clonazepam	0.407	-1.366	Moderate	20 (9/11)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#B1CFE5	2.2169090302464	2.79204451654071e-11
Warfarin	Acetylsalicylic acid	0.262	-3.304	Major	178 (45/133)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#9ABEDB	19.7304903691929	1
Bisoprolol	Insulin detemir	0.262	-2.384	Moderate	166 (53/113)		#A5C6DF	18.4003449510451	1
Fluoxetine	Nortriptyline	0.356	2.385	Major	44 (32/12)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F2ACAC	4.87719986654208	8.23156999870739e-06
Citalopram	Carvedilol	0.349	-1.596	Moderate	233 (96/137)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#AECDE3	25.8269902023705	1
Salbutamol	Carvedilol	0.144	-2.365	Major	352 (113/239)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#A5C6DF	39.0175989323366	1
Zolmitriptan	Escitalopram	0.257	3.622	Major	101 (81/20)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#EB9E9E	11.1953906027443	1
Carvedilol	Escitalopram	0.342	-1.41	None	156 (69/87)		#AFCEE4	17.2918904359219	1
Imipramine	Fluoxetine	0.391	2.683	Major	56 (42/14)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F0A9A9	6.20734528468992	0.0384240194249253
Ciprofloxacin	Acenocoumarol	0.117	-2.506	None	376 (116/260)		#A3C5DF	41.6778897686323	1
Azithromycin	Acenocoumarol	0.091	-1.326	None	306 (140/166)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B1CFE5	33.9187081627699	1
Fluoxetine	Ergotamine	0.227	8.944	Major	77 (70/7)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#D06060	8.53509976644863	1
Citalopram	Sumatriptan	0.317	3.705	Major	108 (87/21)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#EB9E9E	11.9713087633306	1
Trospium	Oxybutynin	0.265	Inf	Moderate	4 (4/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B32020	0.44338180604928	0.61878663877658
Venlafaxine	Almotriptan	0.259	5.068	Major	60 (51/9)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#E38D8D	6.65072709073919	1
Atorvastatin	Colchicine	0.186	-7.603	Major	390 (50/340)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#6B9BC6	43.2297260898048	1
Spironolactone	Irbesartan	0.368	-2.813	Major	109 (31/78)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#A0C3DD	12.0821542148429	1.25065541927517e-05
Atenolol	Insulin aspart	0.307	-1.944	Moderate	189 (69/120)		#ABCBE2	20.9497903358285	1
Repaglinide	Gemfibrozil	0.319	-2.733	Major	124 (36/88)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#A2C4DE	13.7448359875277	1
Enalapril	Lithium cation	0.264	-1.14	Moderate	202 (100/102)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#B2D0E5	22.3907812054886	1
Imipramine	Duloxetine	0.308	2.064	Major	43 (30/13)	Duloxetine may increase the serotonergic activities of Imipramine.	#F4B1B1	4.76635441502976	0.000170839215859154
Atenolol	Formoterol	0.178	-1.222	Moderate	337 (161/176)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B2D0E5	37.3549171596518	1
Phenytoin	Diazepam	0.302	-1.653	Moderate	171 (69/102)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#AECDE3	18.9545722086067	1
Metoprolol	Prazosin	0.844	Inf	Moderate	1 (1/0)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.11084545151232	1
Phenytoin	Topiramate	0.56	-1.677	Moderate	45 (18/27)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#ACCCE3	4.9880453180544	7.99373049171753e-11
Methotrexate	Flurbiprofen	0.319	-1.398	Major	18 (8/10)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#B1CFE5	1.99521812722176	3.35898567165266e-09
Ergotamine	Almotriptan	0.201	4.025	Major	22 (18/4)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#E99999	2.43859993327104	9.46755247196003e-05
Cyclosporine	Tacrolimus	0.187	-1.118	Major	24 (12/12)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	2.66029083629568	0.000563066195601142
Trospium	Solifenacin	0.274	2.012	Moderate	13 (9/4)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#F4B1B1	1.44099086966016	0.0002157209773987
Ibuprofen	Nadolol	0.201	1.648	Moderate	199 (129/70)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F6B6B6	22.0582448509517	1
Levothyroxine	Cholestyramine	0.193	6.35	Moderate	81 (71/10)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#DD7E7E	8.97848157249791	1
Sumatriptan	Escitalopram	0.239	3.769	Major	73 (59/14)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#EB9C9C	8.09171796039935	1
Phenytoin	Acenocoumarol	0.374	-1.342	None	33 (15/18)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	3.65789989990656	1
Cyclosporine	Sevelamer	0.318	2.683	Moderate	4 (3/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#F0A9A9	0.44338180604928	1
Fluoxetine	Almotriptan	0.219	4.635	Major	68 (57/11)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#E69393	7.53749070283775	1
Escitalopram	Rasagiline	0.31	1.118	Major	36 (20/16)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#F9BCBC	3.99043625444352	0.280233152042742
Lovastatin	Verapamil	0.553	1.391	Major	23 (14/9)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F7B9B9	2.54944538478336	0.129162007130083
Digoxin	Hydrochlorothiazide	0.335	-1.531	Moderate	154 (65/89)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#AFCEE4	17.0701995328973	1
Fluoxetine	Sumatriptan	0.208	4.055	Major	83 (68/15)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#E99999	9.20017247552255	1
Phenytoin	Quetiapine	0.398	-2.236	Major	48 (16/32)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#A6C7E0	5.32058167259136	1.92123709612074e-09
Digoxin	Methimazole	0.282	1.661	Moderate	20 (13/7)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F6B6B6	2.2169090302464	0.0510166623894411
Galantamine	Zuclopenthixol	0.316	Inf	None	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#B32020	0.11084545151232	1
Pioglitazone	Gemfibrozil	0.304	-3.416	Major	73 (18/55)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#9ABEDB	8.09171796039935	0.000506333818429603
Pyridostigmine	Fludrocortisone	0.389	1.789	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#F5B4B4	0.33253635453696	0.604176682744343
Acetylsalicylic acid	Dexamethasone	0.197	-2.507	Moderate	334 (103/231)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#A3C5DF	37.0223808051148	1
Disopyramide	Atenolol	0.298	-1.118	Major	8 (4/4)	Disopyramide may increase the bradycardic activities of Atenolol.	#B4D1E6	0.886763612098559	0.00129566588424134
Trazodone	Rivastigmine	0.198	-1.366	Moderate	20 (9/11)		#B1CFE5	2.2169090302464	1.5433324692559e-07
Fluconazole	Amitriptyline	0.209	5.168	Moderate	122 (104/18)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#E38D8D	13.523145084503	1
Diazepam	Itraconazole	0.246	2.364	Moderate	255 (185/70)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F2ACAC	28.2655901356416	1
Diltiazem	Amlodipine	0.358	-3.293	Moderate	217 (55/162)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#9CBFDB	24.0534629781734	1
Indomethacin	Atenolol	0.18	-2.17	Moderate	250 (85/165)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#A8C8E1	27.71136287808	1
Fluvoxamine	Lithium cation	0.398	-1.565	Major	24 (10/14)	Lithium may increase the serotonergic activities of Fluvoxamine.	#AECDE3	2.66029083629568	1.70482250408604e-08
Bisoprolol	Terbutaline	0.105	-1.142	Moderate	190 (94/96)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B2D0E5	21.0606357873408	1
Aprepitant	Dexamethasone	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#B32020	0.11084545151232	1
Fluvoxamine	Duloxetine	0.339	1.67	Major	43 (28/15)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F6B6B6	4.76635441502976	0.251357012115262
Levothyroxine	Warfarin	0.286	2.002	Moderate	68 (47/21)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F4B1B1	7.53749070283775	1
Spironolactone	Mitotane	0.143	Inf	Major	1 (1/0)	The therapeutic efficacy of Mitotane can be decreased when used in combination with Spironolactone.	#B32020	0.11084545151232	1
Formoterol	Carvedilol	0.223	-2.388	Major	185 (59/126)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#A5C6DF	20.5064085297792	1
Sucralfate	Levothyroxine	0.122	7.851	Minor	88 (79/9)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#D56D6D	9.75439973308415	1
Atenolol	Ergotamine	0.282	5.878	Moderate	53 (46/7)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#DF8383	5.87480893015296	1
Nortriptyline	Moclobemide	1	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Nortriptyline.	#B32020	0.11084545151232	1
Paroxetine	Almotriptan	0.27	3.705	Major	72 (58/14)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#EB9E9E	7.98087250888703	1
Cyclosporine	Danazol	0.609	Inf	Moderate	1 (1/0)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#B32020	0.11084545151232	1
Metoprolol	Ibuprofen	0.146	1	Moderate	161 (85/76)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	17.8461176934835	1
Ziprasidone	Donepezil	0.27	1.789	Moderate	3 (2/1)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#F5B4B4	0.33253635453696	0.87698488978505
Atenolol	Terbutaline	0.117	-1.025	Moderate	161 (84/77)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	17.8461176934835	1
Atenolol	Salmeterol	0.229	-1.773	Moderate	256 (99/157)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#ACCCE3	28.3764355871539	1
Fluvoxamine	Tramadol	0.165	3.298	Major	75 (59/16)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#EDA3A3	8.31340886342399	1
Clodronic acid	Iron	0.5	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Spironolactone	Telmisartan	0.326	-2.143	Major	70 (24/46)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#A8C8E1	7.75918160586239	1
Olanzapine	Rivastigmine	0.333	1.118	Moderate	9 (5/4)		#F9BCBC	0.997609063610879	0.0889097654329824
Indomethacin	Furosemide	0.244	-1.617	Moderate	159 (65/94)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#AECDE3	17.6244267904589	1
Trazodone	Galantamine	0.308	-1.304	Moderate	13 (6/7)		#B1CFE5	1.44099086966016	1.61414342870702e-05
Bisoprolol	Verapamil	0.322	-1.342	Major	77 (35/42)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B1CFE5	8.53509976644863	1
Citalopram	Almotriptan	0.254	5.565	Major	65 (56/9)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#E18888	7.20495434830079	1
Naproxen	Lithium cation	0.11	1.38	Major	150 (91/59)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F7B9B9	16.626817726848	1
Diclofenac	Lithium cation	0.114	1.025	Moderate	176 (94/82)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F9BCBC	19.5087994661683	1
Lorazepam	Phenytoin	0.338	-1.634	Moderate	128 (52/76)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#AECDE3	14.1882177935769	1
Lovastatin	Diltiazem	0.423	1.431	Major	26 (16/10)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F7B7B7	2.88198173932032	1
Acetaminophen	Isoniazid	0.22	-1.382	Moderate	199 (89/110)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B1CFE5	22.0582448509517	1
Dihydroergotamine	Fluoxetine	0.231	7.513	Major	47 (42/5)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#D77070	5.20973622107904	1
Fludrocortisone	Primidone	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Primidone.	#B32020	0.11084545151232	1
Lidocaine	Bisoprolol	0.146	1.394	Moderate	87 (53/34)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F7B9B9	9.64355428157183	1
Glyburide	Carvedilol	0.32	-4.696	Moderate	130 (25/105)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#8BB3D4	14.4099086966016	0.0218960560698894
Colestipol	Ursodeoxycholic acid	0.187	2.236	None	7 (5/2)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F2AEAE	0.775918160586239	0.295225087956662
Indomethacin	Bisoprolol	0.164	-2.678	Moderate	275 (81/194)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#A2C4DE	30.482499165888	1
Indomethacin	Losartan	0.156	-2.142	Moderate	242 (83/159)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#A8C8E1	26.8245992659814	1
Phenytoin	Gabapentin	0.434	-1.724	Moderate	61 (24/37)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#ACCCE3	6.76157254225151	1
Doxycycline	Amoxicillin	0.468	1.235	Moderate	300 (174/126)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F8BABA	33.253635453696	1
Chlorpropamide	Carvedilol	0.355	Inf	Moderate	1 (1/0)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.11084545151232	1
Bisoprolol	Insulin glulisine	0.274	-2.795	Moderate	84 (24/60)		#A0C3DD	9.31101792703487	1
Torasemide	Indomethacin	0.146	-1.163	Moderate	102 (50/52)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B2D0E5	11.3062360542566	1
Erythromycin	Atorvastatin	0.11	1.073	Major	143 (78/65)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	15.8508995662617	1
Metoprolol	Clonidine	0.233	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.11084545151232	1
Carvedilol	Insulin detemir	0.294	-4.099	Moderate	70 (15/55)		#93B8D7	7.75918160586239	1.17059700071684e-07
Mirtazapine	Donepezil	0.357	1.118	Moderate	18 (10/8)		#F9BCBC	1.99521812722176	0.0067335530547645
Prazosin	Nadolol	0.466	-6.708	Moderate	7 (1/6)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#74A1CA	0.775918160586239	3.21409170478421e-09
Fluconazole	Clonazepam	0.18	1.571	None	102 (65/37)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F6B6B6	11.3062360542566	1
Olanzapine	Donepezil	0.333	-1.118	Moderate	12 (6/6)		#B4D1E6	1.33014541814784	0.00726923798787101
Omeprazole	Triazolam	0.237	1.586	Moderate	61 (39/22)		#F6B6B6	6.76157254225151	1
Propranolol	Formoterol	0.238	1.052	Major	148 (80/68)		#F9BCBC	16.4051268238233	1
Phenobarbital	Acenocoumarol	0.342	-1.634	None	32 (13/19)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#AECDE3	3.54705444839424	1
Triamcinolone	Acetylsalicylic acid	0.112	-2.491	Moderate	297 (92/205)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#A3C5DF	32.921099099159	1
Propranolol	Gliclazide	0.279	-1.811	None	131 (50/81)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	14.5207541481139	1
Eletriptan	Sertraline	0.203	9.391	Major	23 (21/2)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#CD5A5A	2.54944538478336	1
Ciprofloxacin	Methotrexate	0.113	1.098	Moderate	147 (81/66)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F9BCBC	16.294281372311	1
Cyclosporine	Simvastatin	0.374	-1.993	Major	128 (46/82)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#A9C9E1	14.1882177935769	1
Furosemide	Gentamicin	0.226	-1.677	Major	20 (8/12)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#ACCCE3	2.2169090302464	0.0785388314881285
Methotrexate	Phenylbutazone	0.229	-1.863	Major	8 (3/5)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#ABCBE2	0.886763612098559	0.00125298136309358
Oxycodone	Escitalopram	0.296	1.478	Moderate	61 (38/23)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F7B7B7	6.76157254225151	1
Warfarin	Azathioprine	0.37	1.342	Moderate	10 (6/4)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F7B9B9	1.1084545151232	1
Amitriptyline	Terbutaline	0.193	4.124	Moderate	101 (83/18)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#E89898	11.1953906027443	1
Atenolol	Verapamil	0.325	1.128	Major	52 (29/23)	Verapamil may increase the hypotensive activities of Atenolol.	#F9BCBC	5.76396347864064	1
Paroxetine	Propafenone	0.278	2.385	Moderate	33 (24/9)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F2ACAC	3.65789989990656	1
Dihydroergotamine	Propranolol	0.395	2.236	Moderate	28 (20/8)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F2AEAE	3.10367264234496	1
Atorvastatin	Itraconazole	0.13	-1.525	Major	208 (88/120)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#AFCEE4	23.0558539145625	1
Hydrochlorothiazide	Lithium cation	0.239	1.758	Major	86 (57/29)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F5B4B4	9.53270883005951	1
Indomethacin	Propranolol	0.224	1.917	Moderate	66 (45/21)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F5B2B2	7.31579979981311	1
Eletriptan	Venlafaxine	0.231	5.963	Major	23 (20/3)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#DF8383	2.54944538478336	1
Cyclosporine	Ezetimibe	0.388	-2.571	Moderate	33 (10/23)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#A3C5DF	3.65789989990656	0.00216295417950269
Phenytoin	Ciprofloxacin	0.114	-1.901	Moderate	81 (30/51)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#ABCBE2	8.97848157249791	1
Salmeterol	Carvedilol	0.358	-3.82	Major	159 (36/123)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#96BBD9	17.6244267904589	1
Nabumetone	Alendronic acid	0.144	17.441	Moderate	41 (39/2)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#B32020	4.54466351200512	1
Metoprolol	Escitalopram	0.259	1.699	Minor	29 (19/10)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F5B4B4	3.21451809385728	1
Haloperidol	Propranolol	0.316	-1.553	Moderate	43 (18/25)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#AECDE3	4.76635441502976	1
Cyclosporine	Ticlopidine	0.783	-1.118	Moderate	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.	#B4D1E6	0.22169090302464	1
Fenofibrate	Acenocoumarol	0.297	-5.41	None	181 (31/150)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#83ADD1	20.0630267237299	1
Gemfibrozil	Acenocoumarol	0.301	-5.695	None	195 (32/163)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#80ABCF	21.6148630449024	1
Duloxetine	Flecainide	0.222	2.504	Moderate	38 (28/10)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F1ABAB	4.21212715746816	1
Acitretin	Methotrexate	0.097	-1.597	Major	17 (7/10)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#AECDE3	1.88437267570944	0.000573620637810162
Phenytoin	Megestrol acetate	0.238	-1.118	Moderate	8 (4/4)		#B4D1E6	0.886763612098559	1
Cyclosporine	Fluconazole	0.348	-1.398	Moderate	27 (12/15)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#B1CFE5	2.99282719083264	0.898387771765411
Metoprolol	Fluoxetine	0.277	3.28	Moderate	28 (22/6)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#EDA3A3	3.10367264234496	1
Erythromycin	Sertraline	0.156	5.702	Moderate	59 (51/8)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#E18686	6.53988163922688	1
Oxycodone	Paroxetine	0.252	1.533	Moderate	76 (48/28)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F7B7B7	8.42425431493631	1
Digoxin	Telmisartan	0.337	-1.72	Moderate	33 (13/20)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#ACCCE3	3.65789989990656	1
Fluvastatin	Acenocoumarol	0.338	-3.41	None	81 (20/61)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#9ABEDB	8.97848157249791	0.886525294723691
Imipramine	Carbamazepine	0.453	2.385	Moderate	11 (8/3)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#F2ACAC	1.21929996663552	1
Ziprasidone	Carbamazepine	0.414	-1.342	Minor	11 (5/6)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#B1CFE5	1.21929996663552	0.0044907274736361
Atenolol	Diltiazem	0.274	-2.516	Major	117 (36/81)	Diltiazem may increase the hypotensive activities of Atenolol.	#A3C5DF	12.9689178269414	1
Fluvoxamine	Imipramine	0.37	2.236	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#F2AEAE	0.775918160586239	1
Moxifloxacin	Acenocoumarol	0.089	-1.223	None	67 (32/35)		#B2D0E5	7.42664525132543	1
Prazosin	Verapamil	0.5	Inf	Moderate	1 (1/0)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#B32020	0.11084545151232	1
Trazodone	Ginkgo biloba	0.192	4.651	Moderate	31 (26/5)		#E69393	3.43620899688192	1
Hydrocortisone	Acenocoumarol	0.164	-1.262	None	66 (31/35)		#B2D0E5	7.31579979981311	1
Erythromycin	Citalopram	0.132	2.896	Major	89 (68/21)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#EFA6A6	9.86524518459647	1
Glimepiride	Pregabalin	0.195	-1.757	None	108 (42/66)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#ACCCE3	11.9713087633306	1
Ranolazine	Simvastatin	0.3	-3.214	Major	93 (24/69)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#9CBFDB	10.3086269906458	1
Phenytoin	Vigabatrin	0.863	-1.118	Minor	2 (1/1)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.22169090302464	1
Dihydroergotamine	Sumatriptan	0.38	2.46	Major	15 (11/4)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F2ACAC	1.6626817726848	0.9233145069443
Almotriptan	Sertraline	0.269	4.77	Major	38 (32/6)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#E69191	4.21212715746816	1
Ciprofloxacin	Iron	0.326	-1	Moderate	144 (76/68)		#B4D1E6	15.9617450177741	1
Rosuvastatin	Gemfibrozil	0.255	-3.95	Major	136 (30/106)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#94B9D8	15.0749814056755	1
Norfloxacin	Acenocoumarol	0.1	1.677	None	92 (60/32)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F5B4B4	10.1977815391334	1
Frovatriptan	Escitalopram	0.266	5.814	Major	15 (13/2)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#E08585	1.6626817726848	1
Eletriptan	Escitalopram	0.228	16.1	Major	19 (18/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#B32020	2.10606357873408	1
Fenofibrate	Ursodeoxycholic acid	0.363	-1.012	None	40 (21/19)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#B4D1E6	4.4338180604928	1
Prednisone	Warfarin	0.202	-1.542	Moderate	69 (29/40)	Prednisone may increase the anticoagulant activities of Warfarin.	#AECDE3	7.64833615435007	1
Digoxin	Diazepam	0.226	-1.705	Moderate	149 (59/90)		#ACCCE3	16.5159722753357	1
Erythromycin	Diazepam	0.217	2.431	Moderate	145 (106/39)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F2ACAC	16.0725904692864	1
Doxycycline	Rifampicin	0.72	-1.118	Moderate	14 (7/7)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B4D1E6	1.55183632117248	1
Dihydroergotamine	Rizatriptan	0.304	3.876	Major	16 (13/3)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#EA9B9B	1.77352722419712	1
Phenytoin	Prednisone	0.17	-1.155	Moderate	61 (30/31)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B2D0E5	6.76157254225151	1
Cyclosporine	Metoclopramide	0.201	1.052	Moderate	37 (20/17)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#F9BCBC	4.10128170595584	1
Trazodone	Acenocoumarol	0.287	-1.917	None	95 (35/60)		#ABCBE2	10.5303178936704	1
Dihydroergotamine	Atenolol	0.196	1.453	Moderate	42 (26/16)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B7B7	4.65550896351744	1
Fluvoxamine	Carbamazepine	0.418	1.431	Moderate	13 (8/5)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#F7B7B7	1.44099086966016	1
Rosiglitazone	Gemfibrozil	0.283	-4.053	Moderate	37 (8/29)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#93B8D7	4.10128170595584	0.00514511081051376
Cimetidine	Ketoconazole	1	Inf	Moderate	1 (1/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Cimetidine.	#B32020	0.11084545151232	1
Cyclosporine	Pravastatin	0.499	-3.354	Major	44 (11/33)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#9ABEDB	4.87719986654208	1.82503084914425e-05
Fluvastatin	Gemfibrozil	0.379	-2.662	Major	71 (21/50)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#A2C4DE	7.87002705737471	1
Naproxen	Acenocoumarol	0.104	-1.108	None	217 (109/108)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	24.0534629781734	1
Biperiden	Donepezil	0.166	1.342	Moderate	5 (3/2)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F7B9B9	0.5542272575616	1
Prednisone	Estradiol	0.131	59.926	Moderate	68 (67/1)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	7.53749070283775	1
Cyclosporine	Fluvastatin	0.443	-1.491	Moderate	14 (6/8)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#AFCEE4	1.55183632117248	1
Allopurinol	Warfarin	0.263	-6.957	Moderate	65 (9/56)	Allopurinol may increase the anticoagulant activities of Warfarin.	#719FC9	7.20495434830079	1
Imipramine	Salbutamol	0.174	1.908	Moderate	47 (32/15)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F5B2B2	5.20973622107904	1
Simvastatin	Fusidic acid	0.096	1.001	None	89 (47/42)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#F9BCBC	9.86524518459647	1
Erythromycin	Fluoxetine	0.125	4.83	Moderate	64 (54/10)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#E59090	7.09410889678847	1
Citalopram	Warfarin	0.262	-1.258	Moderate	51 (24/27)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#B2D0E5	5.65311802712832	1
Fluvoxamine	Rizatriptan	0.217	8.944	Major	11 (10/1)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#D06060	1.21929996663552	1
Metoprolol	Sertraline	0.172	4.77	Moderate	19 (16/3)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#E69191	2.10606357873408	1
Omeprazole	Ketoconazole	0.189	1.011	Moderate	98 (52/46)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#F9BCBC	10.8628542482074	1
Erythromycin	Methylprednisolone	0.66	2.114	Moderate	37 (26/11)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F3AFAF	4.10128170595584	1
Fluvoxamine	Moclobemide	0.526	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Moclobemide.	#B32020	0.11084545151232	1
Clozapine	Lamotrigine	0.504	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#B32020	0.22169090302464	1
Acetylsalicylic acid	Heparin	0.625	Inf	Moderate	2 (2/0)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#B32020	0.22169090302464	1
Methylprednisolone	Clarithromycin	0.623	1.168	Major	113 (64/49)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	12.5255360208922	1
Itraconazole	Budesonide	0.314	1.362	Major	164 (99/65)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#F7B9B9	18.1786540480205	1
Cyclosporine	Phenytoin	0.381	-1.118	Moderate	6 (3/3)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B4D1E6	0.665072709073919	1
Tizanidine	Lisinopril	0.156	1.062	Major	70 (38/32)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F9BCBC	7.75918160586239	1
Phenytoin	Trimethoprim	0.192	-1.398	Moderate	18 (8/10)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#B1CFE5	1.99521812722176	1
Cyclosporine	Sirolimus	0.23	-4.472	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#8EB5D5	0.5542272575616	0.00845001581055765
Cyclosporine	Ciprofloxacin	0.149	-2.396	Moderate	66 (21/45)		#A5C6DF	7.31579979981311	1
Phenytoin	Fluoxetine	0.267	-1.384	Moderate	47 (21/26)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B1CFE5	5.20973622107904	1
Eletriptan	Paroxetine	0.222	6.559	Major	25 (22/3)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#DC7B7B	2.771136287808	1
Lovastatin	Gemfibrozil	0.234	-2.112	Major	52 (18/34)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#A8C8E1	5.76396347864064	1
Simvastatin	Rifampicin	0.143	-1.988	Major	100 (36/64)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#A9C9E1	11.084545151232	1
Losartan	Lithium cation	0.353	-1.388	Moderate	65 (29/36)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#B1CFE5	7.20495434830079	1
Colestipol	Levothyroxine	0.256	3.801	Moderate	21 (17/4)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#EB9C9C	2.32775448175872	1
Propranolol	Phenobarbital	0.452	1.342	Moderate	20 (12/8)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F7B9B9	2.2169090302464	1
Ergotamine	Naratriptan	0.503	Inf	Major	3 (3/0)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#B32020	0.33253635453696	1
Pantoprazole	Itraconazole	0.2	1.656	Moderate	77 (50/27)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F6B6B6	8.53509976644863	1
Citalopram	Rasagiline	0.271	1.789	Major	24 (16/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F5B4B4	2.66029083629568	1
Propranolol	Maprotiline	0.3	1.789	Minor	12 (8/4)		#F5B4B4	1.33014541814784	1
Prednisone	Phenobarbital	0.124	-1.272	Moderate	62 (29/33)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B1CFE5	6.87241799376384	1
Azithromycin	Lovastatin	0.087	1.443	Moderate	81 (50/31)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F7B7B7	8.97848157249791	1
Ergotamine	Nadolol	0.209	3.13	Moderate	9 (7/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#EEA4A4	0.997609063610879	1
Prednisone	Rifampicin	0.317	-1.215	Moderate	48 (23/25)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B2D0E5	5.32058167259136	1
Propranolol	Glyburide	0.312	-1.892	Moderate	70 (26/44)	Propranolol may increase the hypoglycemic activities of Glyburide.	#ABCBE2	7.75918160586239	1
Omeprazole	Quazepam	0.178	2.939	Moderate	30 (23/7)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#EFA6A6	3.3253635453696	1
Valsartan	Lithium cation	0.305	-1.118	Moderate	44 (22/22)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#B4D1E6	4.87719986654208	1
Carbamazepine	Oxybutynin	0.229	1.789	None	9 (6/3)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#F5B4B4	0.997609063610879	1
Theophylline	Clarithromycin	0.538	1.133	Moderate	34 (19/15)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#F9BCBC	3.76874535141888	1
Propranolol	Salmeterol	0.278	-1.091	Major	83 (42/41)		#B4D1E6	9.20017247552255	1
Citalopram	Metoprolol	0.345	2.236	Moderate	28 (20/8)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F2AEAE	3.10367264234496	1
Donepezil	Zuclopenthixol	0.043	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Verapamil	Lithium cation	0.324	-2.076	Moderate	20 (7/13)	Verapamil may increase the neurotoxic activities of Lithium.	#A9C9E1	2.2169090302464	0.132967560237974
Venlafaxine	Rasagiline	0.352	1.23	Major	19 (11/8)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#F8BABA	2.10606357873408	1
Phenytoin	Alprazolam	0.32	-1.311	Moderate	63 (29/34)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#B1CFE5	6.98326344527615	1
Warfarin	Paroxetine	0.255	2.087	Moderate	30 (21/9)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F3AFAF	3.3253635453696	1
Gemfibrozil	Ursodeoxycholic acid	0.275	-1.801	None	47 (18/29)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#ACCCE3	5.20973622107904	1
Phenytoin	Sertraline	0.331	1.022	Moderate	30 (16/14)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#F9BCBC	3.3253635453696	1
Piroxicam	Alendronic acid	0.264	9.391	None	23 (21/2)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#CD5A5A	2.54944538478336	1
Diltiazem	Cilostazol	0.268	-4.472	Major	20 (4/16)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#8EB5D5	2.2169090302464	1
Gliclazide	Glucosamine	0.16	1.184	None	79 (45/34)		#F8BABA	8.75679066947327	1
Cyclosporine	Methotrexate	0.23	-2.236	Moderate	21 (7/14)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#A6C7E0	2.32775448175872	0.0488194667536445
Cloxacillin	Acenocoumarol	0.079	-2.38	None	97 (31/66)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#A5C6DF	10.752008796695	1
Verapamil	Carvedilol	0.472	-1.491	Major	21 (9/12)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#AFCEE4	2.32775448175872	1
Ibandronate	Iron	0.219	11.18	Moderate	27 (25/2)		#C44545	2.99282719083264	1
Fludrocortisone	Phenobarbital	0.239	Inf	Moderate	2 (2/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.22169090302464	1
Cyclosporine	Pyrazinamide	0.068	-2.236	Moderate	3 (1/2)	The serum concentration of Cyclosporine can be increased when it is combined with Pyrazinamide.	#A6C7E0	0.33253635453696	1
Sulfasalazine	Mercaptopurine	0.92	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Clarithromycin	Acenocoumarol	0.091	-1.118	None	98 (49/49)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B4D1E6	10.8628542482074	1
Indomethacin	Carvedilol	0.105	-2.289	Moderate	64 (21/43)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#A6C7E0	7.09410889678847	1
Bupropion	Rasagiline	0.361	-1.677	Major	10 (4/6)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#ACCCE3	1.1084545151232	1
Mirtazapine	Rivastigmine	0.356	-2.236	Moderate	15 (5/10)		#A6C7E0	1.6626817726848	0.00889283003036683
Lovastatin	Clarithromycin	0.11	2.108	Major	47 (33/14)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F3AFAF	5.20973622107904	1
Gliclazide	Oxprenolol	0.039	1.789	None	3 (2/1)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#F5B4B4	0.33253635453696	1
Amiodarone	Levofloxacin	0.274	-3.514	Major	87 (21/66)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#99BDDA	9.64355428157183	1
Dihydroergotamine	Nadolol	0.322	1.491	Moderate	8 (5/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#F7B7B7	0.886763612098559	1
Bisoprolol	Ergotamine	0.25	1.565	Moderate	44 (28/16)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F6B6B6	4.87719986654208	1
Nabumetone	Methotrexate	0.26	9.839	Major	12 (11/1)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#CB5555	1.33014541814784	1
Frovatriptan	Sertraline	0.243	2.981	Major	13 (10/3)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#EFA6A6	1.44099086966016	1
Fludrocortisone	Acetylsalicylic acid	0.291	-2.143	Moderate	35 (12/23)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#A8C8E1	3.8795908029312	1
Lidocaine	Propranolol	0.105	1.988	Moderate	29 (20/9)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F4B1B1	3.21451809385728	1
Enalapril	Rifampicin	0.138	-2.881	None	93 (26/67)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#A0C3DD	10.3086269906458	1
Lorazepam	Clozapine	0.291	1.491	Major	16 (10/6)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#F7B7B7	1.77352722419712	1
Cyclosporine	Colchicine	0.412	-1.491	Major	7 (3/4)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#AFCEE4	0.775918160586239	1
Rabeprazole	Itraconazole	0.283	2.882	Moderate	38 (29/9)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F0A7A7	4.21212715746816	1
Sertraline	Rasagiline	0.395	-1.789	Major	26 (10/16)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#ACCCE3	2.88198173932032	1
Clonazepam	Itraconazole	0.162	1.15	None	64 (36/28)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F8BABA	7.09410889678847	1
Sotalol	Ibuprofen	0.156	-1.044	Moderate	58 (30/28)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#B4D1E6	6.42903618771455	1
Ranolazine	Verapamil	0.283	-1.677	Major	5 (2/3)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#ACCCE3	0.5542272575616	1
Propranolol	Repaglinide	0.236	-2.112	Moderate	52 (18/34)		#A8C8E1	5.76396347864064	1
Zolmitriptan	Dihydroergotamine	0.427	Inf	Major	10 (10/0)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#B32020	1.1084545151232	1
Eletriptan	Fluoxetine	0.178	Inf	Major	16 (16/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	1.77352722419712	1
Venlafaxine	Naratriptan	0.266	Inf	Major	7 (7/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.775918160586239	1
Lidocaine	Atenolol	0.121	1.441	Moderate	47 (29/18)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F7B7B7	5.20973622107904	1
Trospium	Olanzapine	0.304	1.789	Moderate	6 (4/2)		#F5B4B4	0.665072709073919	1
Spironolactone	Lisinopril	0.309	-2.924	Major	94 (26/68)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#9FC1DD	10.4194724421581	1
Midazolam	Rifampicin	0.173	2.683	Minor	4 (3/1)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#F0A9A9	0.44338180604928	1
Paroxetine	Frovatriptan	0.201	11.628	None	14 (13/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#C14141	1.55183632117248	1
Levofloxacin	Methotrimeprazine	0.199	-1.97	Moderate	58 (21/37)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#A9C9E1	6.42903618771455	1
Carbamazepine	Verapamil	0.175	1.252	Major	12 (7/5)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F8BABA	1.33014541814784	1
Trospium	Quetiapine	0.489	1.491	Moderate	8 (5/3)		#F7B7B7	0.886763612098559	1
Citalopram	Pimozide	0.279	1.565	Major	11 (7/4)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F6B6B6	1.21929996663552	1
Cyclosporine	Amiodarone	0.357	-4.099	Moderate	14 (3/11)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#93B8D7	1.55183632117248	0.190403964395771
Carbamazepine	Acenocoumarol	0.344	-1.978	None	36 (13/23)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#A9C9E1	3.99043625444352	1
Clozapine	Diazepam	0.375	1.118	Major	18 (10/8)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#F9BCBC	1.99521812722176	1
Tramadol	Rasagiline	0.146	1.214	Major	33 (19/14)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#F8BABA	3.65789989990656	1
Amitriptyline	Pseudoephedrine	0.083	21.466	None	50 (48/2)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	5.542272575616	1
Pimozide	Sertraline	0.465	1.491	Major	8 (5/3)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#F7B7B7	0.886763612098559	1
Trospium	Donepezil	0.339	-1.118	Moderate	2 (1/1)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#B4D1E6	0.22169090302464	1
Pimozide	Escitalopram	0.226	2.236	Major	7 (5/2)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F2AEAE	0.775918160586239	1
Rifabutin	Bupropion	0.1	Inf	None	1 (1/0)	The metabolism of Bupropion can be increased when combined with Rifabutin.	#B32020	0.11084545151232	1
Phenytoin	Mirtazapine	0.334	-1.677	Moderate	25 (10/15)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#ACCCE3	2.771136287808	1
Propranolol	Propafenone	0.359	1.043	Moderate	13 (7/6)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F9BCBC	1.44099086966016	1
Fluconazole	Tacrolimus	0.35	-1.118	Major	42 (21/21)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#B4D1E6	4.65550896351744	1
Itraconazole	Phenobarbital	0.064	2.683	Moderate	12 (9/3)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F0A9A9	1.33014541814784	1
Alprazolam	Ketoconazole	0.133	1.888	Major	28 (19/9)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F5B2B2	3.10367264234496	1
Ramipril	Tizanidine	0.105	-1.321	Major	48 (22/26)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#B1CFE5	5.32058167259136	1
Fluoxetine	Trimipramine	0.376	1.789	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#F5B4B4	0.33253635453696	1
Olanzapine	Galantamine	0.652	-1.118	Moderate	4 (2/2)		#B4D1E6	0.44338180604928	1
Venlafaxine	Frovatriptan	0.221	8.05	Major	10 (9/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#D46A6A	1.1084545151232	1
Chlorpromazine	Propranolol	0.535	-1.118	Moderate	10 (5/5)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#B4D1E6	1.1084545151232	1
Erythromycin	Verapamil	0.07	2.012	Major	13 (9/4)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F4B1B1	1.44099086966016	1
Tacrolimus	Felodipine	0.039	3.578	Moderate	5 (4/1)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#EB9E9E	0.5542272575616	1
Citalopram	Eletriptan	0.31	2.534	Major	23 (17/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#F1ABAB	2.54944538478336	1
Warfarin	Ibuprofen	0.151	-1.737	Major	120 (47/73)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#ACCCE3	13.3014541814784	1
Clarithromycin	Quetiapine	0.138	1.582	Major	72 (46/26)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F6B6B6	7.98087250888703	1
Diazepam	Rifampicin	0.211	-1.29	Minor	56 (26/30)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#B1CFE5	6.20734528468992	1
Lansoprazole	Itraconazole	0.205	1.363	Moderate	53 (32/21)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F7B9B9	5.87480893015296	1
Phenytoin	Hydrocortisone	0.234	-2.096	Moderate	23 (8/15)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#A8C8E1	2.54944538478336	1
Ciprofloxacin	Sevelamer	0.151	-1.626	Moderate	27 (11/16)		#AECDE3	2.99282719083264	1
Doxycycline	Phenobarbital	0.034	1.789	Moderate	9 (6/3)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#F5B4B4	0.997609063610879	1
Cimetidine	Halazepam	1	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Pentoxifylline	Acenocoumarol	0.296	-9.03	None	118 (13/105)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#5A8EBF	13.0797632784538	0.00779753216090036
Pregabalin	Pioglitazone	0.271	-1.841	Moderate	45 (17/28)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#ABCBE2	4.9880453180544	1
Fluvoxamine	Methadone	0.213	Inf	Moderate	1 (1/0)	The metabolism of Methadone can be decreased when combined with Fluvoxamine.	#B32020	0.11084545151232	1
Clozapine	Midazolam	0.268	-1.118	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#B4D1E6	0.22169090302464	1
Atenolol	Glipizide	0.244	-2.076	Moderate	20 (7/13)	Atenolol may increase the hypoglycemic activities of Glipizide.	#A9C9E1	2.2169090302464	1
Glipizide	Carvedilol	0.49	-2.609	Moderate	10 (3/7)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#A3C5DF	1.1084545151232	1
Prednisone	Itraconazole	0.414	1.186	Moderate	107 (61/46)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F8BABA	11.8604633118182	1
Trazodone	Itraconazole	0.149	1.67	Moderate	43 (28/15)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F6B6B6	4.76635441502976	1
Ziprasidone	Chlorpromazine	0.395	-2.236	Major	3 (1/2)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#A6C7E0	0.33253635453696	1
Erythromycin	Warfarin	0.157	2.683	Major	8 (6/2)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#F0A9A9	0.886763612098559	1
Methotrexate	Cloxacillin	0.102	2.033	Major	36 (25/11)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F4B1B1	3.99043625444352	1
Cyclosporine	Diltiazem	0.482	-2.236	Moderate	12 (4/8)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#A6C7E0	1.33014541814784	1
Cyclosporine	Indomethacin	0.213	1.565	Moderate	11 (7/4)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#F6B6B6	1.21929996663552	1
Minocycline	Amoxicillin	0.357	1.15	Moderate	96 (54/42)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F8BABA	10.6411633451827	1
Metoprolol	Ergotamine	0.201	Inf	Moderate	4 (4/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.44338180604928	1
Erythromycin	Levofloxacin	0.714	-1.052	Moderate	66 (34/32)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#B4D1E6	7.31579979981311	1
Esomeprazole	Itraconazole	0.172	1.621	Moderate	45 (29/16)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F6B6B6	4.9880453180544	1
Diltiazem	Rifampicin	0.093	1.789	Major	6 (4/2)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#F5B4B4	0.665072709073919	1
Clozapine	Sertraline	0.426	-1.398	Major	9 (4/5)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#B1CFE5	0.997609063610879	1
Lovastatin	Carbamazepine	0.282	-1.398	None	18 (8/10)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#B1CFE5	1.99521812722176	1
Nabumetone	Acenocoumarol	0.095	1.15	None	16 (9/7)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	1.77352722419712	1
Conjugated estrogens	Ursodeoxycholic acid	0.082	Inf	None	3 (3/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Conjugated estrogens.	#B32020	0.33253635453696	1
Tizanidine	Norethisterone	0.076	Inf	Major	12 (12/0)		#B32020	1.33014541814784	1
Carvedilol	Insulin glulisine	0.231	-6.708	Moderate	35 (5/30)		#74A1CA	3.8795908029312	0.000173179019600235
Mirtazapine	Galantamine	0.12	2.683	Moderate	4 (3/1)		#F0A9A9	0.44338180604928	1
Digoxin	Rabeprazole	0.222	1.093	Moderate	20 (11/9)		#F9BCBC	2.2169090302464	1
Fluoxetine	Warfarin	0.246	1.138	Moderate	25 (14/11)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F8BABA	2.771136287808	1
Paroxetine	Pimozide	0.344	5.367	Major	7 (6/1)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#E28989	0.775918160586239	1
Terbutaline	Carvedilol	0.056	-1.973	Major	47 (17/30)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#A9C9E1	5.20973622107904	1
Indomethacin	Nadolol	0.203	4.025	Moderate	11 (9/2)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#E99999	1.21929996663552	1
Labetalol	Epinephrine	0.062	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.11084545151232	1
Spironolactone	Captopril	0.332	-2.733	Major	31 (9/22)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#A2C4DE	3.43620899688192	1
Eletriptan	Ergotamine	0.231	3.578	Major	5 (4/1)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#EB9E9E	0.5542272575616	1
Cyclosporine	Repaglinide	0.392	-2.795	Major	14 (4/10)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#A0C3DD	1.55183632117248	1
Phenytoin	Flurazepam	0.516	2.683	Moderate	4 (3/1)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#F0A9A9	0.44338180604928	1
Simvastatin	Ketoconazole	0.095	1.514	Major	35 (22/13)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#F7B7B7	3.8795908029312	1
Mirtazapine	Rasagiline	0.396	-1.677	Major	15 (6/9)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#ACCCE3	1.6626817726848	1
Fluoxetine	Naratriptan	0.354	6.261	Major	8 (7/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#DE8080	0.886763612098559	1
Sucralfate	Ibandronate	0.087	Inf	Moderate	11 (11/0)		#B32020	1.21929996663552	1
Diclofenac	Warfarin	0.153	-1.946	Major	74 (27/47)	Diclofenac may increase the anticoagulant activities of Warfarin.	#ABCBE2	8.20256341191167	1
Lovastatin	Warfarin	0.33	-1.677	Moderate	10 (4/6)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#ACCCE3	1.1084545151232	1
Estradiol	Phenobarbital	0.356	2.683	Moderate	8 (6/2)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#F0A9A9	0.886763612098559	1
Atorvastatin	Josamycin	0.131	1.431	None	26 (16/10)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F7B7B7	2.88198173932032	1
Atomoxetine	Fluoxetine	0.386	-1.491	Major	7 (3/4)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#AFCEE4	0.775918160586239	1
Ketoconazole	Atorvastatin	0.141	-1.025	Major	23 (12/11)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#B4D1E6	2.54944538478336	1
Theophylline	Verapamil	0.222	2.683	Moderate	4 (3/1)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#F0A9A9	0.44338180604928	1
Fentanyl	Amiodarone	0.313	-2.516	Major	26 (8/18)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#A3C5DF	2.88198173932032	1
Metoprolol	Paroxetine	0.391	1.391	Moderate	23 (14/9)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F7B9B9	2.54944538478336	1
Trazodone	Warfarin	0.235	-1.398	Minor	18 (8/10)	Trazodone may decrease the anticoagulant activities of Warfarin.	#B1CFE5	1.99521812722176	1
Phenytoin	Oxcarbazepine	0.531	-7.081	Moderate	22 (3/19)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#719FC9	2.43859993327104	2.99692774811559e-08
Fluoxetine	Propafenone	0.269	2.46	Moderate	15 (11/4)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F2ACAC	1.6626817726848	1
Mirtazapine	Clonidine	0.144	1.789	Moderate	3 (2/1)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#F5B4B4	0.33253635453696	1
Theophylline	Ciprofloxacin	0.241	-1.416	Major	34 (15/19)		#AFCEE4	3.76874535141888	1
Warfarin	Levofloxacin	0.155	-1.118	Major	24 (12/12)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#B4D1E6	2.66029083629568	1
Alprazolam	Josamycin	0.075	6.261	None	24 (21/3)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#DE8080	2.66029083629568	1
Amitriptyline	Clonidine	0.103	Inf	Major	3 (3/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.33253635453696	1
Rosuvastatin	Colchicine	0.201	-5.75	Moderate	43 (7/36)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#7FA9CF	4.76635441502976	1
Sertraline	Propafenone	0.26	1.61	Moderate	14 (9/5)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F6B6B6	1.55183632117248	1
Alendronic acid	Ketoprofen	0.16	11.628	Moderate	14 (13/1)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#C14141	1.55183632117248	1
Rifampicin	Clarithromycin	0.538	-1.118	Moderate	24 (12/12)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#B4D1E6	2.66029083629568	1
Betamethasone	Acetylsalicylic acid	0.096	-1.507	Moderate	54 (23/31)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#AFCEE4	5.98565438166528	1
Rifampicin	Atorvastatin	0.122	-3.268	Major	51 (13/38)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#9CBFDB	5.65311802712832	1
Azithromycin	Warfarin	0.105	1.073	Moderate	33 (18/15)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#F9BCBC	3.65789989990656	1
Galantamine	Methotrimeprazine	0.316	-2.236	Moderate	3 (1/2)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#A6C7E0	0.33253635453696	1
Amitriptyline	Moclobemide	0.48	Inf	None	3 (3/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.33253635453696	1
Erythromycin	Acenocoumarol	0.076	-1.358	None	31 (14/17)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B1CFE5	3.43620899688192	1
Lovastatin	Acenocoumarol	0.402	-2.012	None	28 (10/18)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#A9C9E1	3.10367264234496	1
Cyclosporine	Azithromycin	0.11	-1.817	Moderate	42 (16/26)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#ABCBE2	4.65550896351744	1
Sucralfate	Ciprofloxacin	0.439	1.177	Moderate	44 (25/19)		#F8BABA	4.87719986654208	1
Cyclosporine	Ibuprofen	0.145	-2.172	Moderate	103 (35/68)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	11.417081505769	1
Spironolactone	Perindopril	0.413	-3.578	Major	21 (5/16)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#97BCD9	2.32775448175872	1
Diazepam	Josamycin	0.241	4.472	None	30 (25/5)		#E79494	3.3253635453696	1
Glyburide	Glucosamine	0.291	1.036	None	41 (22/19)		#F9BCBC	4.54466351200512	1
Fluvoxamine	Amitriptyline	0.296	2.504	Major	19 (14/5)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F1ABAB	2.10606357873408	1
Levofloxacin	Iron	0.358	1.23	Moderate	57 (33/24)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#F8BABA	6.31819073620224	1
Diltiazem	Tacrolimus	0.325	-1.366	Moderate	20 (9/11)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B1CFE5	2.2169090302464	1
Paroxetine	Rasagiline	0.301	-1.23	Major	21 (10/11)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#B2D0E5	2.32775448175872	1
Glyburide	Oxprenolol	1	Inf	None	1 (1/0)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#B32020	0.11084545151232	1
Phenytoin	Theophylline	0.042	Inf	Moderate	2 (2/0)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#B32020	0.22169090302464	1
Methotrexate	Cholestyramine	0.209	2.087	None	10 (7/3)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F3AFAF	1.1084545151232	1
Prazosin	Bisoprolol	0.317	1.789	Moderate	3 (2/1)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#F5B4B4	0.33253635453696	1
Warfarin	Ranitidine	0.305	-2.795	Moderate	35 (10/25)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#A0C3DD	3.8795908029312	1
Celecoxib	Lithium cation	0.199	6.708	Major	17 (15/2)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#DB7A7A	1.88437267570944	1
Tacrolimus	Metronidazole	0.234	-1.059	Moderate	37 (19/18)		#B4D1E6	4.10128170595584	1
Atorvastatin	Fusidic acid	0.123	-2.311	None	46 (15/31)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#A6C7E0	5.09889076956672	1
Fluconazole	Phenytoin	0.201	1.565	Moderate	11 (7/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#F6B6B6	1.21929996663552	1
Sotalol	Gliclazide	0.206	-1.677	None	10 (4/6)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#ACCCE3	1.1084545151232	1
Torasemide	Gentamicin	0.336	1.342	Major	5 (3/2)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F7B9B9	0.5542272575616	1
Irbesartan	Lithium cation	0.289	1.022	Moderate	15 (8/7)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#F9BCBC	1.6626817726848	1
Erythromycin	Moxifloxacin	0.65	2.385	Major	22 (16/6)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F2ACAC	2.43859993327104	1
Erythromycin	Digoxin	0.246	1.252	Moderate	12 (7/5)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F8BABA	1.33014541814784	1
Doxycycline	Iron	0.392	Inf	Moderate	12 (12/0)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	1.33014541814784	1
Bisoprolol	Epinephrine	0.115	-1.917	Moderate	38 (14/24)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#ABCBE2	4.21212715746816	1
Atomoxetine	Paroxetine	0.128	-1.118	Major	6 (3/3)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B4D1E6	0.665072709073919	1
Terbutaline	Clomipramine	0.149	1.382	Moderate	28 (17/11)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F7B9B9	3.10367264234496	1
Raloxifene	Estradiol	0.21	Inf	Moderate	16 (16/0)		#B32020	1.77352722419712	1
Doxycycline	Methotrexate	0.171	1.64	Moderate	17 (11/6)		#F6B6B6	1.88437267570944	1
Verapamil	Eplerenone	0.435	-3.913	Moderate	9 (2/7)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#94B9D8	0.997609063610879	1
Estradiol	Ursodeoxycholic acid	0.13	Inf	None	9 (9/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.997609063610879	1
Fluvastatin	Cholestyramine	0.4	1.491	Moderate	8 (5/3)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#F7B7B7	0.886763612098559	1
Spironolactone	Eplerenone	0.108	-14.534	Major	42 (3/39)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#1E61A5	4.65550896351744	8.4433628987297e-05
Rifampicin	Glipizide	0.071	Inf	Moderate	1 (1/0)	The serum concentration of Glipizide can be decreased when it is combined with Rifampicin.	#B32020	0.11084545151232	1
Fluconazole	Haloperidol	0.425	-2.36	Major	28 (9/19)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#A5C6DF	3.10367264234496	1
Fluconazole	Cyclophosphamide	0.509	-1.863	None	8 (3/5)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#ABCBE2	0.886763612098559	1
Ergotamine	Isosorbide dinitrate	0.067	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Ergotamine	Itraconazole	0.306	9.839	Major	12 (11/1)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#CB5555	1.33014541814784	1
Metoprolol	Glipizide	0.75	Inf	Moderate	1 (1/0)	Metoprolol may increase the hypoglycemic activities of Glipizide.	#B32020	0.11084545151232	1
Clonidine	Carvedilol	0.378	-2.236	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#A6C7E0	0.33253635453696	1
Carbamazepine	Bupropion	0.261	6.261	Moderate	8 (7/1)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#DE8080	0.886763612098559	1
Meloxicam	Lithium cation	0.07	8.05	Major	10 (9/1)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#D46A6A	1.1084545151232	1
Atorvastatin	Bezafibrate	0.341	-4.721	None	47 (9/38)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#8BB3D4	5.20973622107904	1
Lamotrigine	Norethisterone	0.219	Inf	Moderate	7 (7/0)		#B32020	0.775918160586239	1
Doxycycline	Cloxacillin	0.697	1.022	Moderate	30 (16/14)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#F9BCBC	3.3253635453696	1
Ciprofloxacin	Tizanidine	0.235	-1.019	Major	65 (34/31)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B4D1E6	7.20495434830079	1
Spironolactone	Eprosartan	0.422	-2.422	Major	19 (6/13)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#A5C6DF	2.10606357873408	1
Captopril	Drospirenone	0.062	Inf	Moderate	1 (1/0)	Captopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.11084545151232	1
Testosterone	Acenocoumarol	0.269	-11.18	None	22 (2/20)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#427CB4	2.43859993327104	1
Metronidazole	Acenocoumarol	0.093	-1.621	None	49 (20/29)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#AECDE3	5.43142712410368	1
Ergotamine	Clarithromycin	0.418	6.559	Major	25 (22/3)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#DC7B7B	2.771136287808	1
Pseudoephedrine	Clomipramine	0.15	1.917	None	22 (15/7)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F5B2B2	2.43859993327104	1
Cyclosporine	Lovastatin	0.083	1.342	Major	5 (3/2)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#F7B9B9	0.5542272575616	1
Lovastatin	Tacrolimus	0.169	1.022	Moderate	15 (8/7)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#F9BCBC	1.6626817726848	1
Fluconazole	Ergotamine	0.328	Inf	Moderate	12 (12/0)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#B32020	1.33014541814784	1
Tenoxicam	Alendronic acid	0.185	Inf	None	8 (8/0)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#B32020	0.886763612098559	1
Fludrocortisone	Rifampicin	0.272	-2.236	Moderate	3 (1/2)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#A6C7E0	0.33253635453696	1
Gentamicin	Cefuroxime	0.583	1.193	Moderate	7 (4/3)		#F8BABA	0.775918160586239	1
Ciprofloxacin	Warfarin	0.101	-2.752	Major	45 (13/32)		#A2C4DE	4.9880453180544	1
Fluoxetine	Cilostazol	0.232	1.022	Moderate	15 (8/7)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#F9BCBC	1.6626817726848	1
Bisoprolol	Chlorpropamide	0.062	Inf	Moderate	1 (1/0)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.11084545151232	1
Chlorthalidone	Digoxin	0.543	1.118	Moderate	9 (5/4)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#F9BCBC	0.997609063610879	1
Methylprednisolone	Rifampicin	0.341	-1.118	Moderate	10 (5/5)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#B4D1E6	1.1084545151232	1
Allopurinol	Azathioprine	0.203	-2.236	Major	21 (7/14)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#A6C7E0	2.32775448175872	1
Repaglinide	Clarithromycin	0.092	-1.41	Moderate	52 (23/29)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#AFCEE4	5.76396347864064	1
Cyclosporine	Carbamazepine	0.346	1.342	Major	5 (3/2)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#F7B9B9	0.5542272575616	1
Sumatriptan	Lithium cation	0.259	-1.491	None	14 (6/8)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#AFCEE4	1.55183632117248	1
Dihydroergotamine	Bisoprolol	0.174	1.252	Moderate	24 (14/10)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	2.66029083629568	1
Metronidazole	Lithium cation	0.077	1.789	Moderate	18 (12/6)		#F5B4B4	1.99521812722176	1
Metoprolol	Formoterol	0.15	1.15	Moderate	16 (9/7)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#F8BABA	1.77352722419712	1
Fluconazole	Flurazepam	0.129	3.578	None	10 (8/2)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#EB9E9E	1.1084545151232	1
Fluvoxamine	Eletriptan	0.065	Inf	Major	2 (2/0)	The serum concentration of Eletriptan can be increased when it is combined with Fluvoxamine.	#B32020	0.22169090302464	1
Fluconazole	Halazepam	0.149	6.261	None	8 (7/1)		#DE8080	0.886763612098559	1
Nortriptyline	Salbutamol	0.172	1.789	Moderate	18 (12/6)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F5B4B4	1.99521812722176	1
Fosinopril	Tizanidine	0.546	2.683	Major	4 (3/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#F0A9A9	0.44338180604928	1
Methylprednisolone	Phenobarbital	0.059	-1.304	Moderate	13 (6/7)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#B1CFE5	1.44099086966016	1
Fluconazole	Lovastatin	0.124	1.406	Major	18 (11/7)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F7B9B9	1.99521812722176	1
Tolterodine	Itraconazole	0.171	2.981	Moderate	13 (10/3)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#EFA6A6	1.44099086966016	1
Verapamil	Colchicine	0.264	-2.609	Major	10 (3/7)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#A3C5DF	1.1084545151232	1
Citalopram	Josamycin	0.12	2.907	None	17 (13/4)		#EFA6A6	1.88437267570944	1
Lisinopril	Lithium cation	0.301	-1.806	Moderate	34 (13/21)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#ACCCE3	3.76874535141888	1
Verapamil	Midazolam	0.233	2.683	Moderate	4 (3/1)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F0A9A9	0.44338180604928	1
Fluvoxamine	Theophylline	0.204	-1.118	Major	4 (2/2)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#B4D1E6	0.44338180604928	1
Risperidone	Itraconazole	0.147	3.28	None	14 (11/3)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#EDA3A3	1.55183632117248	1
Indomethacin	Acenocoumarol	0.184	-1.863	None	40 (15/25)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	4.4338180604928	1
Dextropropoxyphene	Acenocoumarol	0.036	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Selegiline	Escitalopram	0.787	-1.118	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#B4D1E6	0.44338180604928	1
Metoprolol	Hydralazine	0.23	-1.118	Minor	2 (1/1)	Hydralazine may increase the hypotensive activities of Metoprolol.	#B4D1E6	0.22169090302464	1
Fluvoxamine	Warfarin	0.192	-1.677	Moderate	5 (2/3)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#ACCCE3	0.5542272575616	1
Phenytoin	Clarithromycin	0.073	-1.118	Moderate	22 (11/11)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B4D1E6	2.43859993327104	1
Metoprolol	Salbutamol	0.149	1.163	Moderate	23 (13/10)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#F8BABA	2.54944538478336	1
Paroxetine	Naratriptan	0.19	Inf	Major	6 (6/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.665072709073919	1
Bisoprolol	Isoprenaline	0.04	Inf	Moderate	1 (1/0)	Bisoprolol may decrease the bronchodilatory activities of Isoprenaline.	#B32020	0.11084545151232	1
Erythromycin	Lincomycin	1	-1.118	Moderate	4 (2/2)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#B4D1E6	0.44338180604928	1
Propranolol	Rifampicin	0.155	1.118	Moderate	9 (5/4)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#F9BCBC	0.997609063610879	1
Midazolam	Clarithromycin	0.188	3.876	Moderate	16 (13/3)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#EA9B9B	1.77352722419712	1
Galantamine	Paroxetine	0.404	-1.677	Moderate	10 (4/6)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#ACCCE3	1.1084545151232	1
Repaglinide	Rifampicin	0.184	1.342	Moderate	5 (3/2)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#F7B9B9	0.5542272575616	1
Propranolol	Terbutaline	0.137	1.214	Major	33 (19/14)		#F8BABA	3.65789989990656	1
Indomethacin	Lithium cation	0.2	1.61	Major	14 (9/5)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F6B6B6	1.55183632117248	1
Ranitidine	Itraconazole	0.318	1.057	Moderate	48 (26/22)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	5.32058167259136	1
Pravastatin	Bezafibrate	0.194	-1.398	None	9 (4/5)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B1CFE5	0.997609063610879	1
Rizatriptan	Moclobemide	0.263	Inf	None	1 (1/0)	The serum concentration of Rizatriptan can be increased when it is combined with Moclobemide.	#B32020	0.11084545151232	1
Haloperidol	Rifampicin	0.271	-1.118	Major	4 (2/2)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#B4D1E6	0.44338180604928	1
Phenytoin	Fludrocortisone	0.248	-1.118	Moderate	2 (1/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#B4D1E6	0.22169090302464	1
Dihydroergotamine	Almotriptan	0.209	1.789	Major	6 (4/2)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#F5B4B4	0.665072709073919	1
Diclofenac	Rifampicin	0.324	-1.926	Moderate	49 (18/31)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#ABCBE2	5.43142712410368	1
Moxifloxacin	Sotalol	0.08	Inf	Major	3 (3/0)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#B32020	0.33253635453696	1
Norfloxacin	Iron	0.277	1.365	None	48 (29/19)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F7B9B9	5.32058167259136	1
Phenytoin	Disulfiram	0.23	-3.913	Moderate	9 (2/7)	The serum concentration of Phenytoin can be increased when it is combined with Disulfiram.	#94B9D8	0.997609063610879	1
Cyclosporine	Verapamil	0.623	-2.236	Moderate	6 (2/4)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#A6C7E0	0.665072709073919	1
Digoxin	Methotrexate	0.103	1.342	Moderate	10 (6/4)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F7B9B9	1.1084545151232	1
Clozapine	Carbamazepine	0.325	-1.118	Major	2 (1/1)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#B4D1E6	0.22169090302464	1
Rifabutin	Clarithromycin	0.646	-1.118	Moderate	4 (2/2)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#B4D1E6	0.44338180604928	1
Diltiazem	Propranolol	0.36	-2.683	Major	34 (10/24)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#A2C4DE	3.76874535141888	1
Itraconazole	Acenocoumarol	0.132	-1.032	None	25 (13/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B4D1E6	2.771136287808	1
Salbutamol	Nadolol	0.246	-1.398	Major	36 (16/20)		#B1CFE5	3.99043625444352	1
Lovastatin	Bezafibrate	0.075	Inf	None	2 (2/0)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#B32020	0.22169090302464	1
Galantamine	Tolterodine	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#B32020	0.11084545151232	1
Carbamazepine	Felodipine	0.68	Inf	Moderate	2 (2/0)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#B32020	0.22169090302464	1
Propranolol	Epinephrine	0.089	2.087	Major	10 (7/3)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F3AFAF	1.1084545151232	1
Prednisolone	Acenocoumarol	0.038	1.789	None	3 (2/1)		#F5B4B4	0.33253635453696	1
Clarithromycin	Solifenacin	0.201	1.431	Major	39 (24/15)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F7B7B7	4.32297260898048	1
Rivastigmine	Methotrimeprazine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Metoprolol	Gliclazide	0.354	-4.472	None	25 (5/20)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#8EB5D5	2.771136287808	1
Amitriptyline	Epinephrine	0.145	3.578	Major	15 (12/3)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#EB9E9E	1.6626817726848	1
Carbamazepine	Itraconazole	0.092	2.012	Moderate	13 (9/4)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F4B1B1	1.44099086966016	1
Almotriptan	Itraconazole	0.13	Inf	Moderate	8 (8/0)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#B32020	0.886763612098559	1
Naratriptan	Escitalopram	0.273	3.578	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#EB9E9E	0.5542272575616	1
Tizanidine	Spirapril	0.333	Inf	None	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Spirapril.	#B32020	0.11084545151232	1
Clonidine	Bisoprolol	0.411	-1.118	Major	4 (2/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	0.44338180604928	1
Amitriptyline	Ketoconazole	0.131	3.13	Moderate	9 (7/2)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#EEA4A4	0.997609063610879	1
Repaglinide	Glucosamine	0.208	-1.376	None	29 (13/16)		#B1CFE5	3.21451809385728	1
Fluconazole	Carbamazepine	0.205	1.789	Moderate	15 (10/5)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F5B4B4	1.6626817726848	1
Amitriptyline	Galantamine	0.241	2.683	Moderate	4 (3/1)		#F0A9A9	0.44338180604928	1
Pyridostigmine	Hydrocortisone	0.33	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B32020	0.33253635453696	1
Pregabalin	Rosiglitazone	0.249	-1.437	Moderate	16 (7/9)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#AFCEE4	1.77352722419712	1
Erythromycin	Lovastatin	0.168	1.043	Major	13 (7/6)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F9BCBC	1.44099086966016	1
Formoterol	Nadolol	0.203	2.236	Major	14 (10/4)		#F2AEAE	1.55183632117248	1
Propranolol	Verapamil	0.394	1.043	Major	13 (7/6)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F9BCBC	1.44099086966016	1
Levofloxacin	Josamycin	0.743	2.683	None	12 (9/3)		#F0A9A9	1.33014541814784	1
Trospium	Risperidone	0.236	-1.677	Moderate	5 (2/3)		#ACCCE3	0.5542272575616	1
Warfarin	Dexamethasone	0.088	Inf	Moderate	4 (4/0)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#B32020	0.44338180604928	1
Biperiden	Rivastigmine	0.111	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B32020	0.11084545151232	1
Doxycycline	Insulin detemir	0.074	Inf	Moderate	5 (5/0)		#B32020	0.5542272575616	1
Warfarin	Leflunomide	0.054	Inf	Moderate	2 (2/0)	Leflunomide may increase the anticoagulant activities of Warfarin.	#B32020	0.22169090302464	1
Atenolol	Epinephrine	0.078	1.491	Moderate	16 (10/6)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B7B7	1.77352722419712	1
Ranolazine	Amiodarone	0.248	-7.826	Major	8 (1/7)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#6898C5	0.886763612098559	1
Cyproheptadine	Fluoxetine	0.538	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B32020	0.22169090302464	1
Spironolactone	Quinapril	0.497	-2.609	Major	10 (3/7)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#A3C5DF	1.1084545151232	1
Alprazolam	Aprepitant	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Alprazolam can be increased when it is combined with Aprepitant.	#B32020	0.11084545151232	1
Ethinylestradiol	Minocycline	1	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Fluconazole	Rifabutin	0.267	-1.118	Moderate	2 (1/1)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#B4D1E6	0.22169090302464	1
Bumetanide	Ibuprofen	0.175	4.025	Moderate	11 (9/2)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#E99999	1.21929996663552	1
Doxycycline	Isotretinoin	0.141	-1.118	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#B4D1E6	0.22169090302464	1
Miglitol	Glucosamine	0.386	1.789	None	3 (2/1)		#F5B4B4	0.33253635453696	1
Trimethoprim	Methotrexate	0.18	2.012	Major	13 (9/4)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F4B1B1	1.44099086966016	1
Citalopram	Frovatriptan	0.16	2.087	Major	10 (7/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#F3AFAF	1.1084545151232	1
Tobramycin	Furosemide	0.113	-10.062	Major	10 (1/9)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#5086BA	1.1084545151232	0.000155590772379532
Piroxicam	Propranolol	0.407	Inf	Moderate	5 (5/0)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#B32020	0.5542272575616	1
Gliclazide	Nadolol	0.231	-1.304	None	13 (6/7)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	1.44099086966016	1
Hydrocortisone	Rifampicin	0.269	-1.957	Moderate	11 (4/7)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#A9C9E1	1.21929996663552	1
Propranolol	Hydralazine	0.433	-1.863	Minor	8 (3/5)	Hydralazine may increase the hypotensive activities of Propranolol.	#ABCBE2	0.886763612098559	1
Dexamethasone	Acenocoumarol	0.237	-3.242	None	39 (10/29)		#9CBFDB	4.32297260898048	1
Citalopram	Naratriptan	0.2	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#B32020	0.5542272575616	1
Nabumetone	Warfarin	0.387	Inf	Major	2 (2/0)	Nabumetone may increase the anticoagulant activities of Warfarin.	#B32020	0.22169090302464	1
Fluoxetine	Josamycin	0.233	4.025	None	11 (9/2)		#E99999	1.21929996663552	1
Sotalol	Glyburide	0.392	-1.118	Moderate	4 (2/2)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	0.44338180604928	1
Disopyramide	Omeprazole	0.308	-1.398	None	9 (4/5)		#B1CFE5	0.997609063610879	1
Sucralfate	Levofloxacin	0.626	-1.118	Moderate	26 (13/13)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	2.88198173932032	1
Phenytoin	Doxycycline	0.052	-1.118	Moderate	6 (3/3)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#B4D1E6	0.665072709073919	1
Chlorpropamide	Acetylsalicylic acid	0.684	Inf	None	1 (1/0)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.11084545151232	1
Prednisone	Estriol	0.251	Inf	None	27 (27/0)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#B32020	2.99282719083264	1
Fluvoxamine	Ergotamine	0.103	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#B32020	0.33253635453696	1
Amitriptyline	Rifampicin	0.224	1.565	Minor	11 (7/4)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#F6B6B6	1.21929996663552	1
Erythromycin	Dihydroergotamine	0.128	4.472	Major	6 (5/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#E79494	0.665072709073919	1
Donepezil	Clomipramine	0.343	-1.118	Moderate	4 (2/2)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#B4D1E6	0.44338180604928	1
Metoprolol	Propafenone	0.575	-2.236	Moderate	3 (1/2)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#A6C7E0	0.33253635453696	1
Cimetidine	Clonazepam	0.24	Inf	Moderate	2 (2/0)		#B32020	0.22169090302464	1
Spironolactone	Benazepril	0.478	-2.236	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#A6C7E0	0.33253635453696	1
Fentanyl	Ketoconazole	0.155	Inf	Major	3 (3/0)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B32020	0.33253635453696	1
Celecoxib	Warfarin	0.08	2.683	Moderate	8 (6/2)	Celecoxib may increase the anticoagulant activities of Warfarin.	#F0A9A9	0.886763612098559	1
Ropinirole	Ciprofloxacin	0.128	-1.118	Moderate	16 (8/8)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B4D1E6	1.77352722419712	1
Dihydroergotamine	Itraconazole	0.206	5.367	Major	7 (6/1)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#E28989	0.775918160586239	1
Fluconazole	Acenocoumarol	0.134	-2.422	None	38 (12/26)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#A5C6DF	4.21212715746816	1
Raloxifene	Cholestyramine	0.125	Inf	Moderate	6 (6/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.665072709073919	1
Carbamazepine	Metronidazole	0.144	-1.901	Moderate	27 (10/17)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#ABCBE2	2.99282719083264	1
Nortriptyline	Carbamazepine	0.708	-1.118	Moderate	4 (2/2)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#B4D1E6	0.44338180604928	1
Metronidazole	Phenobarbital	0.04	-1.677	Moderate	15 (6/9)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#ACCCE3	1.6626817726848	1
Bisoprolol	Glipizide	0.317	-5.59	Moderate	24 (4/20)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#82ACD0	2.66029083629568	1
Duloxetine	Propafenone	0.287	1.118	Moderate	9 (5/4)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F9BCBC	0.997609063610879	1
Warfarin	Hydrocortisone	0.166	1.789	Moderate	6 (4/2)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#F5B4B4	0.665072709073919	1
Dihydroergotamine	Clarithromycin	0.392	5.367	Major	14 (12/2)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#E28989	1.55183632117248	1
Clozapine	Alprazolam	0.216	1.789	Major	6 (4/2)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#F5B4B4	0.665072709073919	1
Norethisterone	Phenobarbital	0.289	2.683	Major	4 (3/1)	The metabolism of Norethisterone can be increased when combined with Phenobarbital.	#F0A9A9	0.44338180604928	1
Carbamazepine	Midazolam	0.209	-1.491	Moderate	7 (3/4)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#AFCEE4	0.775918160586239	1
Diltiazem	Midazolam	0.297	-1.491	Moderate	7 (3/4)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#AFCEE4	0.775918160586239	1
Telmisartan	Lithium cation	0.197	-1.789	Moderate	13 (5/8)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#ACCCE3	1.44099086966016	1
Cyclosporine	Fluoxetine	0.227	1.043	Moderate	13 (7/6)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F9BCBC	1.44099086966016	1
Esomeprazole	Ketoconazole	0.38	1.789	Moderate	6 (4/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#F5B4B4	0.665072709073919	1
Cyclosporine	Rosuvastatin	0.307	-2.236	Major	9 (3/6)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#A6C7E0	0.997609063610879	1
Disulfiram	Acenocoumarol	0.28	-1.957	None	11 (4/7)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#A9C9E1	1.21929996663552	1
Metoprolol	Terbutaline	0.139	-1.398	Moderate	9 (4/5)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#B1CFE5	0.997609063610879	1
Verapamil	Phenobarbital	0.362	1.789	Moderate	3 (2/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#F5B4B4	0.33253635453696	1
Haloperidol	Glycopyrronium	0.495	-2.236	Moderate	6 (2/4)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#A6C7E0	0.665072709073919	1
Phenytoin	Itraconazole	0.046	-1.118	Moderate	8 (4/4)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#B4D1E6	0.886763612098559	1
Ethinylestradiol	Amoxicillin	0.3	Inf	Moderate	12 (12/0)		#B32020	1.33014541814784	1
Cyclosporine	Sulfasalazine	0.071	Inf	Major	1 (1/0)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.11084545151232	1
Fluoxetine	Doxepin	0.167	2.683	Major	4 (3/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#F0A9A9	0.44338180604928	1
Bisoprolol	Rifampicin	0.132	-4.658	Moderate	31 (6/25)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#8BB3D4	3.43620899688192	1
Fentanyl	Itraconazole	0.2	-1.22	Major	23 (11/12)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#B2D0E5	2.54944538478336	1
Theophylline	Propafenone	0.59	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#B32020	0.11084545151232	1
Fluconazole	Tolterodine	0.299	1.193	Moderate	14 (8/6)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F8BABA	1.55183632117248	1
Fluvastatin	Colchicine	0.13	-2.981	Major	11 (3/8)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#9FC1DD	1.21929996663552	1
Cyclosporine	Naproxen	0.103	1.057	Moderate	24 (13/11)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	2.66029083629568	1
Phenytoin	Tacrolimus	0.274	-1.491	Major	7 (3/4)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#AFCEE4	0.775918160586239	1
Ramipril	Lithium cation	0.315	-3.354	Moderate	28 (7/21)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#9ABEDB	3.10367264234496	1
Citalopram	Selegiline	0.083	1.789	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#F5B4B4	0.33253635453696	1
Doxycycline	Acenocoumarol	0.261	-2.396	None	22 (7/15)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#A5C6DF	2.43859993327104	1
Perphenazine	Levofloxacin	0.138	1.073	Moderate	11 (6/5)		#F9BCBC	1.21929996663552	1
Ranitidine	Ketoconazole	0.321	Inf	Moderate	5 (5/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#B32020	0.5542272575616	1
Salbutamol	Doxepin	0.163	-1.398	Moderate	9 (4/5)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#B1CFE5	0.997609063610879	1
Methotrexate	Sulfamethoxazole	0.236	3.13	Moderate	9 (7/2)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#EEA4A4	0.997609063610879	1
Phenoxymethylpenicillin	Methotrexate	0.098	4.472	Major	6 (5/1)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#E79494	0.665072709073919	1
Sotalol	Levofloxacin	0.067	-1.957	Major	11 (4/7)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#A9C9E1	1.21929996663552	1
Indomethacin	Warfarin	0.131	-1.677	Major	10 (4/6)	Indomethacin may increase the anticoagulant activities of Warfarin.	#ACCCE3	1.1084545151232	1
Rifampicin	Dexamethasone	0.306	2.683	Moderate	4 (3/1)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#F0A9A9	0.44338180604928	1
Fluvoxamine	Frovatriptan	0.375	Inf	Major	1 (1/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.11084545151232	1
Duloxetine	Rasagiline	0.295	-1.118	Major	8 (4/4)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#B4D1E6	0.886763612098559	1
Eprosartan	Lithium cation	0.169	1.342	Moderate	5 (3/2)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#F7B9B9	0.5542272575616	1
Donepezil	Methotrimeprazine	0.077	-1.118	Moderate	2 (1/1)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#B4D1E6	0.22169090302464	1
Alprazolam	Cimetidine	0.241	-1.118	Moderate	8 (4/4)		#B4D1E6	0.886763612098559	1
Tacrolimus	Clarithromycin	0.185	2.012	Major	26 (18/8)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F4B1B1	2.88198173932032	1
Moxifloxacin	Amiodarone	0.228	-1.565	Major	12 (5/7)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#AECDE3	1.33014541814784	1
Galantamine	Solifenacin	0.127	-1.118	Moderate	2 (1/1)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#B4D1E6	0.22169090302464	1
Cyclosporine	Ketoprofen	0.091	Inf	Moderate	1 (1/0)	Ketoprofen may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.11084545151232	1
Cyclosporine	Nicardipine	0.182	Inf	Moderate	1 (1/0)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#B32020	0.11084545151232	1
Warfarin	Methimazole	0.111	-1.118	Moderate	4 (2/2)	Methimazole may decrease the anticoagulant activities of Warfarin.	#B4D1E6	0.44338180604928	1
Salbutamol	Rasagiline	0.111	-1.118	Moderate	14 (7/7)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#B4D1E6	1.55183632117248	1
Fluconazole	Fluvastatin	0.109	-1.957	Moderate	22 (8/14)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#A9C9E1	2.43859993327104	1
Indapamide	Lithium cation	0.235	-1.118	Major	10 (5/5)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B4D1E6	1.1084545151232	1
Carbamazepine	Clarithromycin	0.103	1.565	Major	22 (14/8)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F6B6B6	2.43859993327104	1
Fentanyl	Rifampicin	0.314	-4.099	Major	14 (3/11)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#93B8D7	1.55183632117248	1
Itraconazole	Clarithromycin	0.675	1.582	Moderate	36 (23/13)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F6B6B6	3.99043625444352	1
Mefenamic acid	Acenocoumarol	0.231	Inf	None	1 (1/0)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.11084545151232	1
Phenytoin	Sucralfate	0.329	-1.677	Moderate	5 (2/3)		#ACCCE3	0.5542272575616	1
Pyridostigmine	Dexamethasone	0.095	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#B32020	0.22169090302464	1
Fluconazole	Midazolam	0.458	1.491	Major	8 (5/3)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#F7B7B7	0.886763612098559	1
Trospium	Cetirizine	0.265	Inf	None	6 (6/0)		#B32020	0.665072709073919	1
Pravastatin	Colchicine	0.162	-14.311	Major	69 (5/64)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#1F62A5	7.64833615435007	1
Betamethasone	Phenobarbital	0.048	-1.677	Moderate	5 (2/3)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#ACCCE3	0.5542272575616	1
Acenocoumarol	Cholestyramine	0.155	-2.236	None	12 (4/8)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A6C7E0	1.33014541814784	1
Methylphenidate	Rasagiline	0.091	-2.236	Moderate	3 (1/2)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#A6C7E0	0.33253635453696	1
Warfarin	Norfloxacin	0.222	1.043	Major	13 (7/6)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F9BCBC	1.44099086966016	1
Trospium	Tiotropium	0.206	-1.118	Moderate	4 (2/2)	Trospium may increase the anticholinergic activities of Tiotropium.	#B4D1E6	0.44338180604928	1
Erythromycin	Itraconazole	0.751	2.012	Major	13 (9/4)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F4B1B1	1.44099086966016	1
Metoclopramide	Levodopa	0.124	-1.278	Moderate	15 (7/8)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#B1CFE5	1.6626817726848	1
Imipramine	Pseudoephedrine	0.258	3.578	None	5 (4/1)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#EB9E9E	0.5542272575616	1
Atenolol	Piroxicam	0.163	1.342	Moderate	10 (6/4)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F7B9B9	1.1084545151232	1
Hydrocortisone	Phenobarbital	0.067	-2.236	Moderate	12 (4/8)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#A6C7E0	1.33014541814784	1
Labetalol	Ibuprofen	0.11	-1.278	Moderate	15 (7/8)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B1CFE5	1.6626817726848	1
Medroxyprogesterone acetate	Acenocoumarol	0.128	Inf	None	3 (3/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.33253635453696	1
Halazepam	Itraconazole	0.209	Inf	None	4 (4/0)		#B32020	0.44338180604928	1
Conjugated estrogens	Prednisone	0.315	Inf	Moderate	6 (6/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.665072709073919	1
Lovastatin	Fenofibrate	0.384	-2.795	Major	21 (6/15)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#A0C3DD	2.32775448175872	1
Imatinib	Simvastatin	0.1	Inf	Moderate	1 (1/0)	The serum concentration of Simvastatin can be increased when it is combined with Imatinib.	#B32020	0.11084545151232	1
Leflunomide	Acenocoumarol	0.372	1.193	None	7 (4/3)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	0.775918160586239	1
Labetalol	Formoterol	0.533	Inf	Major	2 (2/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.22169090302464	1
Phenytoin	Methotrexate	0.312	-1.118	Moderate	6 (3/3)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#B4D1E6	0.665072709073919	1
Sotalol	Clarithromycin	0.055	3.578	Major	5 (4/1)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#EB9E9E	0.5542272575616	1
Oxcarbazepine	Felodipine	0.091	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Amiodarone	Clarithromycin	0.082	-2.112	Major	26 (9/17)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#A8C8E1	2.88198173932032	1
Halazepam	Ketoconazole	0.083	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Metoprolol	Repaglinide	0.273	-2.795	Moderate	7 (2/5)		#A0C3DD	0.775918160586239	1
Cyclosporine	Norfloxacin	0.104	-1.304	Moderate	13 (6/7)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#B1CFE5	1.44099086966016	1
Tetracycline	Acenocoumarol	0.106	3.578	None	5 (4/1)		#EB9E9E	0.5542272575616	1
Trospium	Hydroxyzine	0.1	Inf	Moderate	3 (3/0)		#B32020	0.33253635453696	1
Celecoxib	Acenocoumarol	0.227	-1.032	None	25 (13/12)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	2.771136287808	1
Trospium	Amitriptyline	0.243	Inf	Moderate	4 (4/0)		#B32020	0.44338180604928	1
Fluconazole	Celecoxib	0.312	1.521	Moderate	27 (17/10)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F7B7B7	2.99282719083264	1
Piroxicam	Methotrexate	0.264	-1.118	Major	6 (3/3)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#B4D1E6	0.665072709073919	1
Atenolol	Prazosin	0.581	-1.118	Moderate	2 (1/1)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#B4D1E6	0.22169090302464	1
Ibuprofen	Oxprenolol	0.166	1.193	None	7 (4/3)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F8BABA	0.775918160586239	1
Lovastatin	Itraconazole	0.07	-1.118	Major	12 (6/6)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#B4D1E6	1.33014541814784	1
Erythromycin	Ergotamine	0.148	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#B32020	0.5542272575616	1
Erythromycin	Cabergoline	0.625	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#B32020	0.22169090302464	1
Propranolol	Glipizide	0.144	-1.118	Moderate	4 (2/2)	Propranolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	0.44338180604928	1
Ketoconazole	Budesonide	0.477	1.431	Major	13 (8/5)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#F7B7B7	1.44099086966016	1
Erythromycin	Carbamazepine	0.121	2.236	Major	7 (5/2)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F2AEAE	0.775918160586239	1
Imipramine	Terbutaline	0.179	3.578	Moderate	5 (4/1)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#EB9E9E	0.5542272575616	1
Lovastatin	Josamycin	0.046	1.789	None	3 (2/1)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#F5B4B4	0.33253635453696	1
Lamotrigine	Ethinylestradiol	0.018	Inf	Moderate	1 (1/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	0.11084545151232	1
Warfarin	Fluvastatin	0.273	-4.472	Minor	10 (2/8)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#8EB5D5	1.1084545151232	1
Betamethasone	Pyridostigmine	0.053	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Betamethasone is combined with Pyridostigmine.	#B32020	0.11084545151232	1
Warfarin	Fenofibrate	0.27	-8.944	Major	27 (3/24)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#5C8FC0	2.99282719083264	1
Carbamazepine	Norethisterone	0.247	Inf	Major	4 (4/0)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#B32020	0.44338180604928	1
Fluvoxamine	Nortriptyline	0.464	-2.236	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#A6C7E0	0.33253635453696	1
Midazolam	Ketoconazole	0.125	Inf	Major	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.	#B32020	0.11084545151232	1
Salmeterol	Nadolol	0.18	-2.236	Major	15 (5/10)		#A6C7E0	1.6626817726848	1
Metoprolol	Lidocaine	0.157	1.789	Moderate	3 (2/1)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#F5B4B4	0.33253635453696	1
Eletriptan	Itraconazole	0.026	Inf	Major	3 (3/0)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B32020	0.33253635453696	1
Warfarin	Pentoxifylline	0.247	-5.031	Moderate	11 (2/9)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#88B0D3	1.21929996663552	1
Allopurinol	Mercaptopurine	0.436	-2.236	Major	3 (1/2)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#A6C7E0	0.33253635453696	1
Alprazolam	Telithromycin	0.121	-1.118	Moderate	6 (3/3)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B4D1E6	0.665072709073919	1
Sotalol	Terbutaline	0.119	Inf	Major	2 (2/0)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#B32020	0.22169090302464	1
Warfarin	Gemfibrozil	0.273	-5.963	Major	19 (3/16)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#7DA8CE	2.10606357873408	1
Fluvoxamine	Almotriptan	0.153	Inf	Major	2 (2/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.22169090302464	1
Phenytoin	Levodopa	0.572	-4.472	Moderate	5 (1/4)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#8EB5D5	0.5542272575616	1
Codeine	Naltrexone	0.22	-1.118	Major	10 (5/5)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#B4D1E6	1.1084545151232	1
Pantoprazole	Ketoconazole	0.471	-1.398	Moderate	9 (4/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#B1CFE5	0.997609063610879	1
Cimetidine	Fentanyl	0.289	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Theophylline	Norfloxacin	0.083	Inf	Moderate	6 (6/0)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#B32020	0.665072709073919	1
Omeprazole	Chlordiazepoxide	0.187	2.683	Moderate	4 (3/1)		#F0A9A9	0.44338180604928	1
Ciprofloxacin	Rasagiline	0.072	-4.025	Major	23 (5/18)		#93B8D7	2.54944538478336	1
Erythromycin	Repaglinide	0.219	1.118	Moderate	9 (5/4)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#F9BCBC	0.997609063610879	1
Rifampicin	Etoricoxib	0.237	-1.677	None	10 (4/6)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#ACCCE3	1.1084545151232	1
Clozapine	Fluoxetine	0.241	1.789	Moderate	3 (2/1)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#F5B4B4	0.33253635453696	1
Valproic acid	Nimodipine	0.263	-3.913	Minor	9 (2/7)		#94B9D8	0.997609063610879	1
Flurazepam	Ketoconazole	0.062	Inf	None	1 (1/0)	The metabolism of Flurazepam can be decreased when combined with Ketoconazole.	#B32020	0.11084545151232	1
Hydrocortisone	Cholestyramine	0.29	1.193	Moderate	7 (4/3)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F8BABA	0.775918160586239	1
Warfarin	Clarithromycin	0.067	-1.118	Major	12 (6/6)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B4D1E6	1.33014541814784	1
Sucralfate	Itraconazole	0.469	2.236	None	7 (5/2)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F2AEAE	0.775918160586239	1
Phenytoin	Medroxyprogesterone acetate	0.5	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.11084545151232	1
Sucralfate	Norfloxacin	0.434	1.118	Moderate	18 (10/8)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F9BCBC	1.99521812722176	1
Dihydroergotamine	Carvedilol	0.105	1.342	Moderate	5 (3/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F7B9B9	0.5542272575616	1
Phenytoin	Norethisterone	0.458	Inf	None	2 (2/0)	The metabolism of Norethisterone can be increased when combined with Phenytoin.	#B32020	0.22169090302464	1
Sirolimus	Itraconazole	0.133	Inf	Major	1 (1/0)	The serum concentration of Sirolimus can be increased when it is combined with Itraconazole.	#B32020	0.11084545151232	1
Chlorthalidone	Lithium cation	0.256	Inf	Major	3 (3/0)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#B32020	0.33253635453696	1
Lithium cation	Etoricoxib	0.156	-1.278	None	15 (7/8)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#B1CFE5	1.6626817726848	1
Indomethacin	Bumetanide	0.4	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.	#B32020	0.11084545151232	1
Itraconazole	Solifenacin	0.327	-1.437	Major	16 (7/9)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#AFCEE4	1.77352722419712	1
Indomethacin	Labetalol	0.03	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#B32020	0.11084545151232	1
Prednisone	Ethinylestradiol	0.317	Inf	Moderate	4 (4/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.44338180604928	1
Glimepiride	Glucosamine	0.162	1.252	None	12 (7/5)		#F8BABA	1.33014541814784	1
Acenocoumarol	Etoricoxib	0.09	-2.134	None	32 (11/21)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#A8C8E1	3.54705444839424	1
Trifluoperazine	Levofloxacin	0.055	Inf	Moderate	2 (2/0)		#B32020	0.22169090302464	1
Formoterol	Oxprenolol	0.077	Inf	None	1 (1/0)	Oxprenolol may decrease the bronchodilatory activities of Formoterol.	#B32020	0.11084545151232	1
Cyclosporine	Methylphenidate	0.167	Inf	Minor	1 (1/0)		#B32020	0.11084545151232	1
Fluoxetine	Rasagiline	0.225	-1.118	Major	8 (4/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#B4D1E6	0.886763612098559	1
Lansoprazole	Ketoconazole	0.422	1.342	Moderate	5 (3/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#F7B9B9	0.5542272575616	1
Donepezil	Tolterodine	0.286	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#B32020	0.11084545151232	1
Telithromycin	Atorvastatin	0.098	1.789	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#F5B4B4	0.33253635453696	1
Nortriptyline	Epinephrine	0.059	Inf	Major	1 (1/0)	Nortriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.11084545151232	1
Theophylline	Phenobarbital	0.037	-1.118	Moderate	2 (1/1)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#B4D1E6	0.22169090302464	1
Primidone	Methylprednisolone	0.091	Inf	Moderate	1 (1/0)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#B32020	0.11084545151232	1
Tizanidine	Cilazapril	0.043	Inf	None	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Cilazapril.	#B32020	0.11084545151232	1
Warfarin	Phenobarbital	0.25	-6.708	Major	7 (1/6)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#74A1CA	0.775918160586239	1
Digoxin	Clarithromycin	0.119	-1.817	Major	21 (8/13)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#ABCBE2	2.32775448175872	1
Triamcinolone	Acenocoumarol	0.131	-3.674	None	30 (7/23)		#97BCD9	3.3253635453696	1
Minocycline	Acenocoumarol	0.129	-2.236	None	9 (3/6)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#A6C7E0	0.997609063610879	1
Ketoconazole	Clonazepam	0.222	-1.118	None	6 (3/3)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B4D1E6	0.665072709073919	1
Dextromethorphan	Selegiline	0.043	Inf	Major	1 (1/0)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#B32020	0.11084545151232	1
Piroxicam	Bisoprolol	0.21	-1.789	Moderate	13 (5/8)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#ACCCE3	1.44099086966016	1
Chlorpromazine	Levofloxacin	0.342	-3.354	Moderate	12 (3/9)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#9ABEDB	1.33014541814784	1
Amitriptyline	Donepezil	0.084	Inf	Moderate	3 (3/0)		#B32020	0.33253635453696	1
Rifampicin	Clomipramine	0.136	Inf	Minor	2 (2/0)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#B32020	0.22169090302464	1
Itraconazole	Ciclesonide	0.08	1.789	Moderate	3 (2/1)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#F5B4B4	0.33253635453696	1
Fluconazole	Warfarin	0.163	-1.491	Major	7 (3/4)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#AFCEE4	0.775918160586239	1
Diazepam	Ketoconazole	0.285	1.193	Moderate	14 (8/6)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F8BABA	1.55183632117248	1
Medroxyprogesterone acetate	Phenobarbital	0.5	Inf	Moderate	1 (1/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.11084545151232	1
Moxifloxacin	Iron	0.343	2.385	Moderate	11 (8/3)		#F2ACAC	1.21929996663552	1
Sotalol	Repaglinide	0.278	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Disulfiram	Isoniazid	0.25	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#B32020	0.11084545151232	1
Repaglinide	Glipizide	0.154	-4.472	None	5 (1/4)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#8EB5D5	0.5542272575616	1
Ketoconazole	Quetiapine	0.127	-1.118	Major	4 (2/2)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#B4D1E6	0.44338180604928	1
Prednisolone	Acetylsalicylic acid	0.175	-1.863	Moderate	8 (3/5)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#ABCBE2	0.886763612098559	1
Estradiol	Prednisolone	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#B32020	0.11084545151232	1
Lidocaine	Carvedilol	0.077	-2.795	Moderate	14 (4/10)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#A0C3DD	1.55183632117248	1
Terbinafine	Acenocoumarol	0.141	-3.727	None	26 (6/20)		#96BBD9	2.88198173932032	1
Dextromethorphan	Rasagiline	0.177	1.342	Major	5 (3/2)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#F7B9B9	0.5542272575616	1
Theophylline	Disulfiram	0.193	-3.354	Moderate	4 (1/3)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#9ABEDB	0.44338180604928	1
Itraconazole	Aripiprazole	0.081	1.789	Moderate	6 (4/2)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F5B4B4	0.665072709073919	1
Pioglitazone	Glucosamine	0.17	-2.795	None	14 (4/10)		#A0C3DD	1.55183632117248	1
Codeine	Cimetidine	0.299	2.683	Moderate	4 (3/1)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#F0A9A9	0.44338180604928	1
Citalopram	Clozapine	0.364	1.789	Major	3 (2/1)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#F5B4B4	0.33253635453696	1
Tizanidine	Captopril	0.51	3.578	Major	5 (4/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#EB9E9E	0.5542272575616	1
Rifampicin	Acenocoumarol	0.261	-3.913	None	9 (2/7)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#94B9D8	0.997609063610879	1
Itraconazole	Quazepam	0.077	Inf	None	1 (1/0)	The metabolism of Quazepam can be decreased when combined with Itraconazole.	#B32020	0.11084545151232	1
Cyclosporine	Oxcarbazepine	0.125	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Cyclophosphamide	Acenocoumarol	0.278	-3.354	None	4 (1/3)		#9ABEDB	0.44338180604928	1
Eletriptan	Clarithromycin	0.067	4.472	Major	6 (5/1)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#E79494	0.665072709073919	1
Eplerenone	Lithium cation	0.238	-5.59	Moderate	6 (1/5)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#82ACD0	0.665072709073919	1
Sertraline	Cilostazol	0.348	-5.59	Moderate	18 (3/15)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#82ACD0	1.99521812722176	1
Digoxin	Indapamide	0.341	-2.609	Moderate	10 (3/7)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#A3C5DF	1.1084545151232	1
Tacrolimus	Itraconazole	0.548	-1.677	Major	15 (6/9)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#ACCCE3	1.6626817726848	1
Phenytoin	Estradiol	0.117	1.789	Moderate	3 (2/1)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#F5B4B4	0.33253635453696	1
Minocycline	Iron	0.252	Inf	Moderate	3 (3/0)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.33253635453696	1
Fluvoxamine	Phenytoin	0.274	-4.472	Moderate	5 (1/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#8EB5D5	0.5542272575616	1
Famotidine	Itraconazole	0.086	-1.677	Moderate	5 (2/3)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#ACCCE3	0.5542272575616	1
Terbutaline	Rasagiline	0.066	-1.118	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#B4D1E6	0.44338180604928	1
Erythromycin	Quetiapine	0.079	5.367	Major	7 (6/1)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#E28989	0.775918160586239	1
Metoprolol	Epinephrine	0.067	-1.118	Moderate	2 (1/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B4D1E6	0.22169090302464	1
Erythromycin	Theophylline	0.398	1.789	Moderate	3 (2/1)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#F5B4B4	0.33253635453696	1
Cyclosporine	Digoxin	0.101	-2.236	Moderate	3 (1/2)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#A6C7E0	0.33253635453696	1
Tetracycline	Amoxicillin	0.557	2.236	Moderate	28 (20/8)		#F2AEAE	3.10367264234496	1
Atenolol	Insulin glulisine	0.196	-3.913	Moderate	18 (4/14)		#94B9D8	1.99521812722176	1
Warfarin	Minocycline	0.161	-1.118	Moderate	2 (1/1)	Minocycline may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.22169090302464	1
Minocycline	Cloxacillin	0.815	-1.398	Moderate	9 (4/5)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#B1CFE5	0.997609063610879	1
Trospium	Cyclobenzaprine	0.357	Inf	Moderate	3 (3/0)		#B32020	0.33253635453696	1
Phenytoin	Midazolam	0.152	-5.59	Moderate	6 (1/5)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#82ACD0	0.665072709073919	1
Fluconazole	Dihydroergotamine	0.407	-1.398	Moderate	9 (4/5)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#B1CFE5	0.997609063610879	1
Morphine	Rifampicin	0.34	-5.59	Moderate	6 (1/5)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#82ACD0	0.665072709073919	1
Fluconazole	Imipramine	0.101	2.683	Moderate	4 (3/1)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F0A9A9	0.44338180604928	1
Fluconazole	Eplerenone	0.067	-5.031	Moderate	11 (2/9)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#88B0D3	1.21929996663552	1
Ergotamine	Frovatriptan	0.282	-1.118	Major	2 (1/1)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B4D1E6	0.22169090302464	1
Tramadol	Moclobemide	0.124	1.789	None	3 (2/1)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#F5B4B4	0.33253635453696	1
Sucralfate	Ofloxacin	0.067	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Sertraline	Moclobemide	0.034	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Sertraline is combined with Moclobemide.	#B32020	0.11084545151232	1
Fluconazole	Pimozide	0.333	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Fluconazole.	#B32020	0.11084545151232	1
Prednisone	Ketoconazole	0.585	-2.012	Moderate	14 (5/9)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#A9C9E1	1.55183632117248	1
Warfarin	Cloxacillin	0.276	1.342	Moderate	5 (3/2)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#F7B9B9	0.5542272575616	1
Clozapine	Bromazepam	0.306	-2.236	None	3 (1/2)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#A6C7E0	0.33253635453696	1
Cyclosporine	Nabumetone	0.071	Inf	Moderate	1 (1/0)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.11084545151232	1
Warfarin	Cholestyramine	0.39	-4.472	Moderate	5 (1/4)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#8EB5D5	0.5542272575616	1
Naratriptan	Sertraline	0.041	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#B32020	0.22169090302464	1
Phenytoin	Amiodarone	0.578	-5.59	Moderate	6 (1/5)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#82ACD0	0.665072709073919	1
Sucralfate	Ketoconazole	0.062	Inf	Minor	1 (1/0)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.11084545151232	1
Ergotamine	Carvedilol	0.104	1.342	Moderate	5 (3/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F7B9B9	0.5542272575616	1
Trospium	Ipratropium	0.059	2.683	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F0A9A9	0.44338180604928	1
Digoxin	Hydroxychloroquine	0.274	-1.118	Moderate	4 (2/2)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#B4D1E6	0.44338180604928	1
Amitriptyline	Rasagiline	0.294	-1.863	Major	8 (3/5)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#ABCBE2	0.886763612098559	1
Fluvastatin	Bezafibrate	0.527	-6.708	None	7 (1/6)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#74A1CA	0.775918160586239	1
Betamethasone	Rifampicin	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Betamethasone can be decreased when it is combined with Rifampicin.	#B32020	0.11084545151232	1
Carteolol	Ibuprofen	0.143	Inf	Moderate	1 (1/0)	Ibuprofen may decrease the antihypertensive activities of Carteolol.	#B32020	0.11084545151232	1
Eletriptan	Dihydroergotamine	0.083	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#B32020	0.11084545151232	1
Phenytoin	Mebendazole	0.035	-1.118	Moderate	2 (1/1)	The serum concentration of Mebendazole can be decreased when it is combined with Phenytoin.	#B4D1E6	0.22169090302464	1
Cyclosporine	Clarithromycin	0.202	1.789	Major	6 (4/2)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#F5B4B4	0.665072709073919	1
Tetracycline	Insulin glulisine	0.143	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Haloperidol	Itraconazole	0.216	-1.863	Moderate	8 (3/5)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#ABCBE2	0.886763612098559	1
Ethinylestradiol	Acenocoumarol	0.019	Inf	None	1 (1/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.11084545151232	1
Fluconazole	Nortriptyline	0.089	-1.118	Moderate	4 (2/2)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B4D1E6	0.44338180604928	1
Venlafaxine	Propafenone	0.441	-1.118	Moderate	6 (3/3)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#B4D1E6	0.665072709073919	1
Fluoxetine	Frovatriptan	0.441	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#B32020	0.33253635453696	1
Triazolam	Itraconazole	0.1	Inf	Major	1 (1/0)	The serum concentration of Triazolam can be increased when it is combined with Itraconazole.	#B32020	0.11084545151232	1
Tizanidine	Perindopril	0.141	-1.118	Major	4 (2/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#B4D1E6	0.44338180604928	1
Doxycycline	Acitretin	0.052	-1.118	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#B4D1E6	0.22169090302464	1
Donepezil	Solifenacin	0.308	-3.354	Moderate	4 (1/3)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#9ABEDB	0.44338180604928	1
Erythromycin	Sotalol	0.034	Inf	Major	1 (1/0)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#B32020	0.11084545151232	1
Acetaminophen	Imatinib	0.2	Inf	Moderate	1 (1/0)	Acetaminophen may increase the hepatotoxic activities of Imatinib.	#B32020	0.11084545151232	1
Imipramine	Terbinafine	0.103	Inf	Moderate	2 (2/0)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#B32020	0.22169090302464	1
Triamcinolone	Warfarin	0.115	-2.795	Moderate	7 (2/5)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#A0C3DD	0.775918160586239	1
Dextromethorphan	Terbinafine	0.53	1.61	Major	14 (9/5)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F6B6B6	1.55183632117248	1
Primidone	Metronidazole	0.031	Inf	Moderate	1 (1/0)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#B32020	0.11084545151232	1
Digoxin	Josamycin	0.143	Inf	None	1 (1/0)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#B32020	0.11084545151232	1
Tizanidine	Donepezil	0.403	-1.118	Moderate	2 (1/1)	Tizanidine may increase the bradycardic activities of Donepezil.	#B4D1E6	0.22169090302464	1
Imipramine	Epinephrine	0.071	Inf	Major	1 (1/0)	Imipramine may decrease the antihypertensive activities of Epinephrine.	#B32020	0.11084545151232	1
Dihydroergotamine	Isosorbide mononitrate	0.067	Inf	Moderate	1 (1/0)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#B32020	0.11084545151232	1
Carbamazepine	Ketoconazole	0.029	-1.118	Moderate	2 (1/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#B4D1E6	0.22169090302464	1
Glyburide	Nadolol	0.299	-4.472	Moderate	10 (2/8)	Nadolol may increase the hypoglycemic activities of Glyburide.	#8EB5D5	1.1084545151232	1
Doxycycline	Digoxin	0.138	-2.795	Moderate	7 (2/5)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#A0C3DD	0.775918160586239	1
Meloxicam	Acenocoumarol	0.179	-1.342	None	11 (5/6)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	1.21929996663552	1
Losartan	Drospirenone	0.023	Inf	Moderate	1 (1/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.11084545151232	1
Captopril	Lithium cation	0.241	-1.677	Moderate	5 (2/3)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#ACCCE3	0.5542272575616	1
Eplerenone	Clarithromycin	0.12	-4.472	Major	15 (3/12)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#8EB5D5	1.6626817726848	1
Clarithromycin	Colchicine	0.31	-2.236	Major	15 (5/10)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#A6C7E0	1.6626817726848	1
Phenytoin	Methylprednisolone	0.082	-3.354	Moderate	8 (2/6)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#9ABEDB	0.886763612098559	1
Fluconazole	Rifampicin	0.746	-2.236	Major	6 (2/4)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#A6C7E0	0.665072709073919	1
Erythromycin	Midazolam	0.667	-1.118	Moderate	4 (2/2)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#B4D1E6	0.44338180604928	1
Fluvoxamine	Acenocoumarol	0.223	-3.354	None	8 (2/6)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#9ABEDB	0.886763612098559	1
Fludrocortisone	Acenocoumarol	0.248	-3.354	None	4 (1/3)		#9ABEDB	0.44338180604928	1
Capecitabine	Acenocoumarol	0.155	-3.354	None	4 (1/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#9ABEDB	0.44338180604928	1
Methylprednisolone	Itraconazole	0.15	-1.118	Major	12 (6/6)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#B4D1E6	1.33014541814784	1
Moxifloxacin	Warfarin	0.145	-3.354	Major	8 (2/6)		#9ABEDB	0.886763612098559	1
Fluphenazine	Levofloxacin	0.254	-1.677	Moderate	5 (2/3)		#ACCCE3	0.5542272575616	1
Sotalol	Formoterol	0.114	-1.118	Major	4 (2/2)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.44338180604928	1
Fluconazole	Triazolam	0.077	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.11084545151232	1
Paroxetine	Selegiline	0.8	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#B32020	0.11084545151232	1
Topiramate	Ethinylestradiol	0.178	Inf	Moderate	1 (1/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	0.11084545151232	1
Lamotrigine	Rifampicin	0.089	-2.236	Moderate	3 (1/2)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#A6C7E0	0.33253635453696	1
Disulfiram	Metronidazole	0.107	-2.236	Major	9 (3/6)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#A6C7E0	0.997609063610879	1
Trospium	Clomipramine	0.314	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Itraconazole	Josamycin	0.417	1.789	None	3 (2/1)		#F5B4B4	0.33253635453696	1
Losartan	Rifampicin	0.178	-7.826	Moderate	24 (3/21)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#6898C5	2.66029083629568	1
Warfarin	Naproxen	0.129	-2.556	Major	23 (7/16)	Naproxen may increase the anticoagulant activities of Warfarin.	#A3C5DF	2.54944538478336	1
Cyclosporine	Clindamycin	0.091	-5.031	Moderate	11 (2/9)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#88B0D3	1.21929996663552	1
Verapamil	Nadolol	0.023	Inf	Major	1 (1/0)	Verapamil may increase the hypotensive activities of Nadolol.	#B32020	0.11084545151232	1
Triamcinolone	Phenobarbital	0.106	-1.677	Moderate	5 (2/3)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#ACCCE3	0.5542272575616	1
Moxifloxacin	Josamycin	0.667	-1.118	None	4 (2/2)		#B4D1E6	0.44338180604928	1
Epinephrine	Clomipramine	0.073	1.789	Major	3 (2/1)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#F5B4B4	0.33253635453696	1
Alendronic acid	Flurbiprofen	0.229	-1.677	Moderate	5 (2/3)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#ACCCE3	0.5542272575616	1
Metoprolol	Diltiazem	0.719	-3.354	Major	4 (1/3)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#9ABEDB	0.44338180604928	1
Colestipol	Hydrocortisone	1	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.11084545151232	1
Fluvoxamine	Dihydroergotamine	0.575	-1.118	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#B4D1E6	0.22169090302464	1
Paroxetine	Moclobemide	0.57	-2.236	None	3 (1/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#A6C7E0	0.33253635453696	1
Galantamine	Sertraline	0.465	-2.236	Moderate	3 (1/2)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#A6C7E0	0.33253635453696	1
Clomipramine	Rasagiline	0.221	-2.236	Major	3 (1/2)	Rasagiline may increase the serotonergic activities of Clomipramine.	#A6C7E0	0.33253635453696	1
Citalopram	Moclobemide	0.633	-1.118	None	2 (1/1)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#B4D1E6	0.22169090302464	1
Diltiazem	Carbamazepine	0.273	-3.354	Major	8 (2/6)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#9ABEDB	0.886763612098559	1
Moxifloxacin	Sucralfate	0.331	1.342	Moderate	5 (3/2)		#F7B9B9	0.5542272575616	1
Nifedipine	Phenobarbital	0.627	-2.236	Major	3 (1/2)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#A6C7E0	0.33253635453696	1
Digoxin	Minocycline	0.21	-3.354	Moderate	4 (1/3)		#9ABEDB	0.44338180604928	1
Cyclosporine	Diclofenac	0.204	-3.54	Moderate	25 (6/19)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#99BDDA	2.771136287808	1
Carbamazepine	Isoniazid	0.177	-1.118	Moderate	2 (1/1)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#B4D1E6	0.22169090302464	1
Ergotamine	Nitroglycerin	0.299	-1.863	Moderate	8 (3/5)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#ABCBE2	0.886763612098559	1
Perindopril	Lithium cation	0.044	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B32020	0.11084545151232	1
Ergotamine	Isosorbide mononitrate	0.132	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Midazolam	Itraconazole	0.2	-1.677	Major	5 (2/3)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#ACCCE3	0.5542272575616	1
Theophylline	Pentoxifylline	0.3	-4.472	Moderate	5 (1/4)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#8EB5D5	0.5542272575616	1
Trandolapril	Tizanidine	0.02	-1.118	Major	2 (1/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B4D1E6	0.22169090302464	1
Simvastatin	Telithromycin	0.059	-1.677	Major	5 (2/3)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#ACCCE3	0.5542272575616	1
Carbamazepine	Josamycin	0.75	-1.118	None	2 (1/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#B4D1E6	0.22169090302464	1
Griseofulvin	Acetylsalicylic acid	0.048	Inf	Minor	1 (1/0)		#B32020	0.11084545151232	1
Erythromycin	Tacrolimus	0.135	Inf	Major	3 (3/0)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#B32020	0.33253635453696	1
Galantamine	Cyclobenzaprine	0.057	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Ticlopidine	Acetylsalicylic acid	0.24	-14.534	Moderate	14 (1/13)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#1E61A5	1.55183632117248	1
Flurazepam	Itraconazole	0.118	-2.236	None	6 (2/4)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#A6C7E0	0.665072709073919	1
Amitriptyline	Cimetidine	0.077	Inf	Moderate	1 (1/0)	The metabolism of Amitriptyline can be decreased when combined with Cimetidine.	#B32020	0.11084545151232	1
Terbutaline	Nadolol	0.109	-2.236	Major	6 (2/4)		#A6C7E0	0.665072709073919	1
Fluvoxamine	Oxycodone	0.274	-1.118	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#B4D1E6	0.22169090302464	1
Felodipine	Itraconazole	0.229	-1.118	Major	2 (1/1)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#B4D1E6	0.22169090302464	1
Repaglinide	Josamycin	0.097	-4.472	None	5 (1/4)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#8EB5D5	0.5542272575616	1
Doxycycline	Warfarin	0.14	-3.354	Moderate	4 (1/3)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#9ABEDB	0.44338180604928	1
Tacrolimus	Rifampicin	0.071	Inf	Major	1 (1/0)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#B32020	0.11084545151232	1
Phenoxymethylpenicillin	Tetracycline	1	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Doxycycline	Insulin glulisine	0.056	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Nortriptyline	Terbinafine	0.069	-1.118	Moderate	2 (1/1)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#B4D1E6	0.22169090302464	1
Tetracycline	Insulin detemir	0.074	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Digoxin	Itraconazole	0.369	-1.118	Major	4 (2/2)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#B4D1E6	0.44338180604928	1
Cyclosporine	Glyburide	0.185	-2.236	Moderate	3 (1/2)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#A6C7E0	0.33253635453696	1
Moxifloxacin	Ziprasidone	0.021	Inf	Major	1 (1/0)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.11084545151232	1
Warfarin	Etoricoxib	0.284	-1.118	None	4 (2/2)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#B4D1E6	0.44338180604928	1
Tamoxifen	Rifampicin	0.111	Inf	Moderate	1 (1/0)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#B32020	0.11084545151232	1
Cyclosporine	Erythromycin	0.278	-1.118	Major	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#B4D1E6	0.22169090302464	1
Eplerenone	Itraconazole	0.049	-3.354	Major	4 (1/3)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#9ABEDB	0.44338180604928	1
Erythromycin	Rifampicin	0.333	Inf	Moderate	1 (1/0)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B32020	0.11084545151232	1
Metoprolol	Glyburide	0.471	-11.18	Moderate	11 (1/10)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#427CB4	1.21929996663552	1
Methylphenidate	Carbamazepine	0.29	-4.472	None	5 (1/4)		#8EB5D5	0.5542272575616	1
Pimozide	Clarithromycin	0.083	Inf	Major	1 (1/0)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#B32020	0.11084545151232	1
Clozapine	Ciprofloxacin	0.09	-3.354	Major	4 (1/3)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#9ABEDB	0.44338180604928	1
Repaglinide	Nadolol	0.14	-4.472	Moderate	5 (1/4)		#8EB5D5	0.5542272575616	1
Trospium	Loratadine	0.061	1.789	None	3 (2/1)		#F5B4B4	0.33253635453696	1
Methylprednisolone	Ketoconazole	0.091	Inf	Major	1 (1/0)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#B32020	0.11084545151232	1
Fluvoxamine	Sumatriptan	0.057	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B32020	0.11084545151232	1
Ethinylestradiol	Etoricoxib	0.5	Inf	None	1 (1/0)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	0.11084545151232	1
Rifabutin	Simvastatin	0.333	Inf	None	1 (1/0)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#B32020	0.11084545151232	1
Ketoprofen	Acenocoumarol	0.095	Inf	None	1 (1/0)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.11084545151232	1
Methotrexate	Ketoprofen	0.237	-3.354	Major	4 (1/3)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#9ABEDB	0.44338180604928	1
Doxycycline	Insulin aspart	0.077	-2.795	Moderate	7 (2/5)		#A0C3DD	0.775918160586239	1
Isoniazid	Acenocoumarol	0.178	-7.826	None	8 (1/7)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#6898C5	0.886763612098559	1
Trospium	Desloratadine	0.101	-2.236	None	3 (1/2)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#A6C7E0	0.33253635453696	1
Dextromethorphan	Memantine	0.583	-1.118	Minor	2 (1/1)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#B4D1E6	0.22169090302464	1
Lidocaine	Nadolol	0.025	Inf	Moderate	1 (1/0)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B32020	0.11084545151232	1
Theophylline	Terbinafine	0.031	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#B32020	0.11084545151232	1
Triamcinolone	Rifampicin	0.333	Inf	Moderate	1 (1/0)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#B32020	0.11084545151232	1
Labetalol	Salbutamol	0.681	-2.236	Major	3 (1/2)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#A6C7E0	0.33253635453696	1
Phenobarbital	Estriol	0.111	Inf	None	1 (1/0)		#B32020	0.11084545151232	1
Piroxicam	Acenocoumarol	0.2	Inf	None	1 (1/0)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.11084545151232	1
Nortriptyline	Terbutaline	0.034	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#B32020	0.11084545151232	1
Enalapril	Drospirenone	0.089	-1.118	Moderate	2 (1/1)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#B4D1E6	0.22169090302464	1
Prednisone	Primidone	0.07	-3.354	Moderate	4 (1/3)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#9ABEDB	0.44338180604928	1
Trazodone	Ketoconazole	1	Inf	Moderate	1 (1/0)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B32020	0.11084545151232	1
Fluvoxamine	Tizanidine	0.178	-1.118	Major	2 (1/1)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#B4D1E6	0.22169090302464	1
Fluvoxamine	Zolmitriptan	0.171	Inf	Moderate	1 (1/0)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#B32020	0.11084545151232	1
Theophylline	Acyclovir	0.031	Inf	Minor	1 (1/0)		#B32020	0.11084545151232	1
Metoprolol	Indomethacin	0.075	-5.59	Moderate	6 (1/5)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#82ACD0	0.665072709073919	1
Warfarin	Itraconazole	0.261	-2.236	Moderate	3 (1/2)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#A6C7E0	0.33253635453696	1
Erythromycin	Colchicine	0.048	-2.236	Major	3 (1/2)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#A6C7E0	0.33253635453696	1
Rifampicin	Gliclazide	0.119	-11.18	None	11 (1/10)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#427CB4	1.21929996663552	1
Theophylline	Propranolol	0.1	Inf	Major	1 (1/0)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B32020	0.11084545151232	1
Tetracycline	Insulin aspart	0.069	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Erythromycin	Amiodarone	0.125	-8.944	Major	9 (1/8)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#5C8FC0	0.997609063610879	1
Doxycycline	Phenoxymethylpenicillin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#B32020	0.11084545151232	1
Methotrexate	Tetracycline	0.2	Inf	Moderate	1 (1/0)		#B32020	0.11084545151232	1
Metoprolol	Salmeterol	0.25	-4.472	Moderate	5 (1/4)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#8EB5D5	0.5542272575616	1
Warfarin	Metronidazole	0.083	-1.118	Major	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#B4D1E6	0.22169090302464	1
Tetracycline	Iron	0.611	-2.236	Moderate	3 (1/2)		#A6C7E0	0.33253635453696	1
Betamethasone	Acenocoumarol	0.108	-1.118	None	2 (1/1)		#B4D1E6	0.22169090302464	1
Doxycycline	Carbamazepine	0.037	-3.354	Moderate	4 (1/3)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#9ABEDB	0.44338180604928	1
Cimetidine	Diazepam	0.591	Inf	Moderate	1 (1/0)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#B32020	0.11084545151232	1
Cyclobenzaprine	Rasagiline	0.288	-3.354	Major	4 (1/3)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#9ABEDB	0.44338180604928	1
Celecoxib	Rifampicin	0.167	-3.354	Moderate	4 (1/3)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#9ABEDB	0.44338180604928	1
Dihydroergotamine	Nitroglycerin	0.144	-2.236	Moderate	3 (1/2)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#A6C7E0	0.33253635453696	1
Tetracycline	Cloxacillin	1	-1.118	Moderate	2 (1/1)		#B4D1E6	0.22169090302464	1
Thiethylperazine	Levofloxacin	0.589	-4.099	None	14 (3/11)		#93B8D7	1.55183632117248	1
Ceftazidime	Tobramycin	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	0.753396249680442
Prazosin	Propranolol	0.53	-Inf	Moderate	10 (0/10)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	1.1084545151232	4.00291187347759e-07
Cyclosporine	Rifabutin	0.07	-Inf	None	2 (0/2)	The metabolism of Cyclosporine can be increased when combined with Rifabutin.	#1E61A5	0.22169090302464	1
Tobramycin	Cefonicid	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Methylergometrine	Nitroglycerin	1	-Inf	Moderate	4 (0/4)	The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.	#1E61A5	0.44338180604928	0.00773591561723941
Clozapine	Rivastigmine	0.391	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Metoprolol	Disopyramide	1	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Metoprolol.	#1E61A5	0.11084545151232	1
Clozapine	Donepezil	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#1E61A5	0.11084545151232	1
Gentamicin	Cefonicid	0.571	-Inf	Moderate	2 (0/2)		#1E61A5	0.22169090302464	1
Donepezil	Periciazine	0.462	-Inf	None	1 (0/1)		#1E61A5	0.11084545151232	1
Diltiazem	Buspirone	0.281	-Inf	Moderate	3 (0/3)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#1E61A5	0.33253635453696	0.566770436521899
Ziprasidone	Pimozide	0.517	-Inf	Major	1 (0/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#1E61A5	0.11084545151232	1
Ziprasidone	Galantamine	0.455	-Inf	Moderate	1 (0/1)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.11084545151232	1
Dextropropoxyphene	Naltrexone	0.5	-Inf	None	1 (0/1)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#1E61A5	0.11084545151232	1
Methadone	Rifampicin	0.208	-Inf	Major	2 (0/2)	The serum concentration of Methadone can be decreased when it is combined with Rifampicin.	#1E61A5	0.22169090302464	1
Atomoxetine	Propafenone	0.031	-Inf	Moderate	1 (0/1)	The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.	#1E61A5	0.11084545151232	1
Cyclosporine	Rifampicin	0.286	-Inf	Major	5 (0/5)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#1E61A5	0.5542272575616	1
Eplerenone	Tolevamer	0.229	-Inf	None	7 (0/7)		#1E61A5	0.775918160586239	1
Trihexyphenidyl	Rivastigmine	0.25	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#1E61A5	0.11084545151232	1
Galantamine	Oxybutynin	0.455	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#1E61A5	0.11084545151232	1
Trospium	Imipramine	0.026	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Dihydroergotamine	Frovatriptan	0.571	-Inf	Major	1 (0/1)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#1E61A5	0.11084545151232	1
Fluvoxamine	Clozapine	0.8	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#1E61A5	0.11084545151232	1
Primidone	Acenocoumarol	0.074	-Inf	None	5 (0/5)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#1E61A5	0.5542272575616	1
Fluvoxamine	Doxepin	0.167	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#1E61A5	0.11084545151232	1
Clozapine	Rifampicin	0.133	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be decreased when it is combined with Rifampicin.	#1E61A5	0.11084545151232	1
Megestrol acetate	Phenobarbital	0.473	-Inf	Moderate	4 (0/4)		#1E61A5	0.44338180604928	1
Theophylline	Josamycin	0.514	-Inf	None	2 (0/2)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#1E61A5	0.22169090302464	1
Imipramine	Rivastigmine	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Ticlopidine	Carbamazepine	0.336	-Inf	Moderate	2 (0/2)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#1E61A5	0.22169090302464	1
Phenobarbital	Dexamethasone	0.232	-Inf	Moderate	9 (0/9)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.997609063610879	1
Chlorpromazine	Donepezil	0.143	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#1E61A5	0.11084545151232	1
Glipizide	Nadolol	0.711	-Inf	Moderate	2 (0/2)	Nadolol may increase the hypoglycemic activities of Glipizide.	#1E61A5	0.22169090302464	1
Disopyramide	Propranolol	0.333	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.11084545151232	1
Doxycycline	Benzylpenicillin	1	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Doxycycline.	#1E61A5	0.11084545151232	1
Moclobemide	Clomipramine	0.217	-Inf	None	1 (0/1)	Moclobemide may increase the serotonergic activities of Clomipramine.	#1E61A5	0.11084545151232	1
Nateglinide	Glucosamine	0.033	-Inf	None	1 (0/1)		#1E61A5	0.11084545151232	1
Tobramycin	Cefuroxime	0.667	-Inf	Moderate	2 (0/2)		#1E61A5	0.22169090302464	1
Donepezil	Oxybutynin	0.7	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#1E61A5	0.11084545151232	1
Cyclosporine	Phenobarbital	0.283	-Inf	Moderate	3 (0/3)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#1E61A5	0.33253635453696	1
Diltiazem	Triazolam	0.156	-Inf	Moderate	2 (0/2)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#1E61A5	0.22169090302464	1
Phenytoin	Prednisolone	0.5	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#1E61A5	0.11084545151232	1
Hydromorphone	Naltrexone	0.244	-Inf	Major	1 (0/1)	The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Naltrexone.	#1E61A5	0.11084545151232	1
Doxycycline	Ampicillin	1	-Inf	Moderate	2 (0/2)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#1E61A5	0.22169090302464	1
Phenytoin	Triazolam	0.033	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Triazolam.	#1E61A5	0.11084545151232	1
Clozapine	Ketazolam	0.326	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Ketazolam.	#1E61A5	0.11084545151232	1
Pyridostigmine	Methylprednisolone	0.195	-Inf	Moderate	3 (0/3)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#1E61A5	0.33253635453696	1
Amitriptyline	Rivastigmine	0.225	-Inf	Moderate	3 (0/3)		#1E61A5	0.33253635453696	1
Galantamine	Biperiden	0.583	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#1E61A5	0.11084545151232	1
Digoxin	Sulfasalazine	0.178	-Inf	Moderate	3 (0/3)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#1E61A5	0.33253635453696	1
Galantamine	Glycopyrronium	0.077	-Inf	None	1 (0/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#1E61A5	0.11084545151232	1
Ticlopidine	Phenytoin	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#1E61A5	0.11084545151232	1
Colestipol	Fluvastatin	0.604	-Inf	Moderate	2 (0/2)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.22169090302464	1
Ampicillin	Acenocoumarol	0.085	-Inf	None	3 (0/3)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.33253635453696	1
Felodipine	Josamycin	0.048	-Inf	None	1 (0/1)		#1E61A5	0.11084545151232	1
Lovastatin	Colchicine	0.239	-Inf	Major	9 (0/9)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#1E61A5	0.997609063610879	1
Benazepril	Tizanidine	0.018	-Inf	Major	1 (0/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Benazepril.	#1E61A5	0.11084545151232	1
Carbamazepine	Doxepin	0.038	-Inf	Moderate	1 (0/1)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#1E61A5	0.11084545151232	1
Warfarin	Primidone	0.083	-Inf	Major	1 (0/1)	The metabolism of Warfarin can be increased when combined with Primidone.	#1E61A5	0.11084545151232	1
Atenolol	Clonidine	0.11	-Inf	Major	2 (0/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#1E61A5	0.22169090302464	1
Ofloxacin	Acenocoumarol	0.087	-Inf	None	6 (0/6)		#1E61A5	0.665072709073919	1
Galantamine	Clomipramine	0.061	-Inf	Moderate	1 (0/1)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#1E61A5	0.11084545151232	1
Cilostazol	Itraconazole	0.124	-Inf	Major	7 (0/7)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.775918160586239	1
Piroxicam	Carvedilol	0.227	-Inf	Moderate	4 (0/4)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#1E61A5	0.44338180604928	1
Testosterone	Warfarin	0.108	-Inf	Major	4 (0/4)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.44338180604928	1
Fluvoxamine	Ropinirole	0.125	-Inf	Moderate	1 (0/1)	Fluvoxamine may increase the sedative activities of Ropinirole.	#1E61A5	0.11084545151232	1
Fluconazole	Cilostazol	0.088	-Inf	Major	7 (0/7)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#1E61A5	0.775918160586239	1
Amitriptyline	Phenylephrine	0.333	-Inf	Major	1 (0/1)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#1E61A5	0.11084545151232	1
Glimepiride	Rifampicin	0.219	-Inf	Moderate	4 (0/4)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#1E61A5	0.44338180604928	1
Midazolam	Josamycin	0.071	-Inf	None	1 (0/1)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#1E61A5	0.11084545151232	1
Morphine	Naltrexone	0.115	-Inf	Major	2 (0/2)	The therapeutic efficacy of Morphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.22169090302464	1
Folic acid	Primidone	0.214	-Inf	Moderate	2 (0/2)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#1E61A5	0.22169090302464	1
Phenytoin	Rifampicin	0.129	-Inf	Major	2 (0/2)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.22169090302464	1
Colestipol	Warfarin	0.667	-Inf	Minor	1 (0/1)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.11084545151232	1
Alfuzosin	Itraconazole	0.087	-Inf	Major	6 (0/6)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	0.665072709073919	1
Warfarin	Rifampicin	0.138	-Inf	Major	2 (0/2)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#1E61A5	0.22169090302464	1
Warfarin	Isoniazid	0.152	-Inf	Moderate	2 (0/2)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#1E61A5	0.22169090302464	1
Glycopyrronium	Rivastigmine	0.211	-Inf	None	1 (0/1)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#1E61A5	0.11084545151232	1
Prazosin	Carvedilol	0.417	-Inf	Moderate	1 (0/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.11084545151232	1
Metoprolol	Piroxicam	0.167	-Inf	Moderate	1 (0/1)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#1E61A5	0.11084545151232	1
Erythromycin	Eletriptan	0.111	-Inf	Major	1 (0/1)	The serum concentration of Eletriptan can be increased when it is combined with Erythromycin.	#1E61A5	0.11084545151232	1
Cyclosporine	Glipizide	0.3	-Inf	Moderate	1 (0/1)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#1E61A5	0.11084545151232	1
Pseudoephedrine	Doxepin	0.5	-Inf	None	1 (0/1)	Doxepin may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.11084545151232	1
Imipramine	Rifampicin	0.105	-Inf	Minor	1 (0/1)	The metabolism of Imipramine can be increased when combined with Rifampicin.	#1E61A5	0.11084545151232	1
Epinephrine	Carvedilol	0.057	-Inf	Major	4 (0/4)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#1E61A5	0.44338180604928	1
Verapamil	Rifampicin	0.053	-Inf	Moderate	2 (0/2)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#1E61A5	0.22169090302464	1
Clarithromycin	Everolimus	0.041	-Inf	Major	3 (0/3)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#1E61A5	0.33253635453696	1
Rivastigmine	Clomipramine	0.189	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Ampicillin	Methotrexate	1	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Ampicillin.	#1E61A5	0.11084545151232	1
Fluvoxamine	Rasagiline	0.125	-Inf	Major	1 (0/1)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#1E61A5	0.11084545151232	1
Griseofulvin	Acenocoumarol	0.095	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.11084545151232	1
Ketoconazole	Rabeprazole	0.196	-Inf	Moderate	2 (0/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#1E61A5	0.22169090302464	1
Colestipol	Digoxin	1	-Inf	Moderate	1 (0/1)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.11084545151232	1
Naltrexone	Buprenorphine	0.5	-Inf	Major	1 (0/1)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.11084545151232	1
Colestipol	Acenocoumarol	0.334	-Inf	None	2 (0/2)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.22169090302464	1
Spironolactone	Fosinopril	0.411	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#1E61A5	0.22169090302464	1
Haloperidol	Ketoconazole	0.025	-Inf	Major	1 (0/1)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#1E61A5	0.11084545151232	1
Labetalol	Glyburide	0.4	-Inf	Moderate	1 (0/1)	Labetalol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.11084545151232	1
Indomethacin	Sotalol	0.142	-Inf	Moderate	2 (0/2)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#1E61A5	0.22169090302464	1
Pseudoephedrine	Rasagiline	0.187	-Inf	Moderate	2 (0/2)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#1E61A5	0.22169090302464	1
Carbamazepine	Warfarin	0.641	-Inf	Moderate	2 (0/2)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#1E61A5	0.22169090302464	1
Lovastatin	Ketoconazole	0.022	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#1E61A5	0.11084545151232	1
Glyburide	Rifampicin	0.187	-Inf	Moderate	3 (0/3)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#1E61A5	0.33253635453696	1
Ziprasidone	Amiodarone	1	-Inf	Major	1 (0/1)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#1E61A5	0.11084545151232	1
Spironolactone	Cilazapril	0.333	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#1E61A5	0.11084545151232	1
Mercaptopurine	Acenocoumarol	0.542	-Inf	None	1 (0/1)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#1E61A5	0.11084545151232	1
Warfarin	Meloxicam	0.215	-Inf	Major	2 (0/2)	Meloxicam may increase the anticoagulant activities of Warfarin.	#1E61A5	0.22169090302464	1
Trandolapril	Lithium cation	0.791	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#1E61A5	0.11084545151232	1
Cyclosporine	Glimepiride	0.25	-Inf	Moderate	2 (0/2)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#1E61A5	0.22169090302464	1
Erythromycin	Felodipine	0.02	-Inf	Moderate	1 (0/1)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#1E61A5	0.11084545151232	1
Phenytoin	Betamethasone	0.026	-Inf	Moderate	1 (0/1)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#1E61A5	0.11084545151232	1
Metformin	Cimetidine	0.094	-Inf	Moderate	2 (0/2)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#1E61A5	0.22169090302464	1
Hydroxyzine	Rivastigmine	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Quinapril	Lithium cation	0.083	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#1E61A5	0.11084545151232	1
Metoprolol	Verapamil	0.75	-Inf	Major	1 (0/1)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#1E61A5	0.11084545151232	1
Fluconazole	Everolimus	0.769	-Inf	Major	1 (0/1)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#1E61A5	0.11084545151232	1
Fluvoxamine	Cilostazol	0.028	-Inf	Major	1 (0/1)	The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine.	#1E61A5	0.11084545151232	1
Tenoxicam	Acenocoumarol	0.088	-Inf	None	1 (0/1)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.11084545151232	1
Clozapine	Lisinopril	0.167	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#1E61A5	0.11084545151232	1
Phenytoin	Warfarin	0.5	-Inf	Moderate	1 (0/1)	Phenytoin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.11084545151232	1
Erythromycin	Eplerenone	0.034	-Inf	Moderate	2 (0/2)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#1E61A5	0.22169090302464	1
Glimepiride	Ketoconazole	0.027	-Inf	None	1 (0/1)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#1E61A5	0.11084545151232	1
Ofloxacin	Iron	0.2	-Inf	None	1 (0/1)		#1E61A5	0.11084545151232	1
Lovastatin	Rifampicin	0.067	-Inf	Major	1 (0/1)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#1E61A5	0.11084545151232	1
Cyclosporine	Bupropion	0.417	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.11084545151232	1
Tizanidine	Quinapril	0.242	-Inf	Major	1 (0/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#1E61A5	0.11084545151232	1
Rifampicin	Bupropion	0.273	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be increased when combined with Rifampicin.	#1E61A5	0.11084545151232	1
Digoxin	Cholestyramine	0.375	-Inf	Moderate	1 (0/1)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.11084545151232	1
Cyclobenzaprine	Rivastigmine	0.353	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Naltrexone	Fentanyl	0.333	-Inf	Major	1 (0/1)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#1E61A5	0.11084545151232	1
Donepezil	Cyclobenzaprine	0.167	-Inf	Moderate	1 (0/1)		#1E61A5	0.11084545151232	1
Rifampicin	Nifedipine	0.231	-Inf	Major	1 (0/1)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#1E61A5	0.11084545151232	1
Rifampicin	Fluvastatin	0.106	-Inf	Moderate	1 (0/1)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#1E61A5	0.11084545151232	1
Atenolol	Ampicillin	0.031	-Inf	Moderate	1 (0/1)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#1E61A5	0.11084545151232	1
Fluconazole	Ranolazine	0.154	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#1E61A5	0.11084545151232	1
Cyclosporine	Terbinafine	0.103	-Inf	Minor	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#1E61A5	0.11084545151232	1
Sirolimus	Clarithromycin	0.022	-Inf	Major	1 (0/1)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#1E61A5	0.11084545151232	1
Warfarin	Disulfiram	0.222	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#1E61A5	0.11084545151232	1
Ketoconazole	Acenocoumarol	0.18	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#1E61A5	0.11084545151232	1
Cyclosporine	Itraconazole	0.053	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#1E61A5	0.11084545151232	1
Phenytoin	Triamcinolone	0.027	-Inf	Moderate	1 (0/1)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#1E61A5	0.11084545151232	1
Ranolazine	Clarithromycin	0.067	-Inf	Major	1 (0/1)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#1E61A5	0.11084545151232	1
